Vuzix (VUZI) 10-K 31 Mar 15 2014 FY Annual report Financial data

Document_And_Entity_Informatio

Document And Entity Information (USD $)	12 Months Ended
	Dec. 31, 2014	Mar. 27, 2015	Jun. 30, 2014
Document Information [Line Items]
Document Type	10-K
Amendment Flag	FALSE
Document Period End Date	31-Dec-14
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	FY
Entity Registrant Name	Vuzix Corp
Entity Central Index Key	1463972
Current Fiscal Year End Date	-19
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Smaller Reporting Company
Entity Public Float			$16,035,000
Trading Symbol	VUZI
Entity Common Stock, Shares Outstanding		15,862,418

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Dec. 31, 2014	Dec. 31, 2013
Current Assets
Cash and Cash Equivalents	$84,967	$310,140
Accounts Receivable, Net	383,533	214,920
Inventories, Net (Note 2)	911,949	953,627
Prepaid Expenses and Other Assets	579,000	200,936
Total Current Assets	1,959,449	1,679,623
Tooling and Equipment, Net (Note 3)	416,965	446,329
Patents and Trademarks, Net (Note 4)	423,489	495,608
Software Development Costs, Net (Note 5)	787,738	240,561
Debt Issuance Costs, Net (Note 6)	112,521	0
Total Assets	3,700,162	2,862,121
Current Liabilities
Accounts Payable	2,183,565	2,420,571
Line of Credit (Note 7)	112,500	0
Notes Payable (Note 8)	37,038	278,467
Current Portion of Long-term Debt, net of discount (Note 11)	128,425	99,320
Current Portion of Capital Leases	16,882	24,670
Customer Deposits	120,550	131,077
Unearned Revenue	53,403	39,700
Accrued Expenses (Note 9)	699,067	591,199
Income and Other Taxes Payable	35,158	75,851
Total Current Liabilities	3,386,588	3,660,855
Long-Term Liabilities
Long-Term Derivative Liability (Note 10)	13,541,138	12,035,816
Long-Term Portion of Term Debt, net of discount (Note 11)	1,088,996	170,496
Long-Term Portion of Capital Leases (Note 12)	0	16,882
Long-Term Portion of Accrued Interest	81,451	16,365
Total Long-Term Liabilities	14,711,585	12,239,559
Total Liabilities	18,098,173	15,900,414
Stockholders’ Deficit
Preferred Stock — $.001 Par Value, 5,000,000 Shares Authorized; 0 Shares Issued and Outstanding in Each Period	0	0
Common Stock — $.001 Par Value, 100,000,000 Shares Authorized December 31, 2014 and 700,000,000 Shares Authorized December 31, 2013; 11,295,387 Shares Issued and Outstanding December 31, 2014 and 9,600,453 on December 31, 2013	11,296	9,600
Additional Paid-in Capital	29,752,083	23,244,639
Accumulated Deficit	-44,161,390	-36,292,532
Total Stockholders’ Deficit	-14,398,011	-13,038,293
Total Liabilities and Stockholders’ Deficit	$3,700,162	$2,862,121

CONSOLIDATED_BALANCE_SHEETS_Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Preferred Stock, Par Value	$0.00	$0.00
Preferred Stock, Shares Authorized	5,000,000	5,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Common Stock, Par Value	$0.00	$0.00
Common Stock, Shares Authorized	100,000,000	700,000,000
Common Stock, Shares Issued	11,295,387	9,600,453
Common Stock, Shares Outstanding	11,295,387	9,600,453

CONSOLIDATED_STATEMENTS_OF_CHA

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (USD $)		Total	Common Stock		Additional Paid-in Capital	Accumulated Deficit	Preferred Stock	Subscription Receivable
Balance at Dec. 31, 2012		($6,209,565)	$3,537		$19,933,202	($26,146,304)	$0	$0
Balance (in shares) at Dec. 31, 2012			3,536,865	[1]			0
Issuance of Common Stock in Public Offering (in shares)	[1]		4,025,000
Issuance of Common Stock in Public Offering		8,050,000	4,025		8,045,975
Direct Financing Associated Costs		-1,358,641			-1,358,641
Conversion of Term Debt and Accrued Interest (in shares)	[1]		1,158,003
Conversion of Term Debt and Accrued Interest		2,316,007	1,158		2,314,849
Conversion of Accrued Compensation and Interest (in shares)	[1]		821,285
Conversion of Accrued Compensation and Interest		1,642,569	821		1,641,748
Exercise of Warrants (in shares)	[1]		59,300
Exercise of Warrants		133,425	59		133,366
Stock Compensation Expense		159,272	0		159,272	0	0	0
Issuance of Warrants in Conjunction with Public Offering		-8,236,786			-8,236,786
Reclass Fair Value of Warrant Derivative Liability upon Expiration of Full Ratchet Price Protection		526,245			526,245
Reclass Fair Value of Warrant Derivative Liability upon Exercise		85,409			85,409
Net (Loss)		-10,146,228	0		0	-10,146,228	0	0
Balance at Dec. 31, 2013		-13,038,293	9,600		23,244,639	-36,292,532	0	0
Balance (in shares) at Dec. 31, 2013			9,600,453	[1]			0
Exercise of Warrants (in shares)	[1]		1,228,582
Exercise of Warrants		2,682,695	1,229		2,681,466
Stock Compensation Expense		260,746	0		260,746	0	0	0
Conversion of Note Payable (in shares)	[1]		277,778
Conversion of Note Payable		373,159	278		372,881
Stock Issues for Services (in shares)	[1]		188,574
Stock Issues for Services		564,874	189		564,685
Reclass Fair Value of Derivative Liability upon note conversion		500,261			500,261
Reclass Fair Value of Warrant Derivative Liability upon Exercise		2,127,405			2,127,405
Net (Loss)		-7,868,858	0		0	-7,868,858	0	0
Balance at Dec. 31, 2014		($14,398,011)	$11,296		$29,752,083	($44,161,390)	$0	$0
Balance (in shares) at Dec. 31, 2014			11,295,387	[1]			0
[1]	All share amounts for all periods reflect the Company’s 1-for-75 reverse stock split, which was effective February 6, 2013.

CONSOLIDATED_STATEMENTS_OF_OPE

CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Sales of Products	$2,474,559	$1,856,806
Sales of Engineering Services	557,517	532,247
Total Sales	3,032,076	2,389,053
Cost of Sales — Products	1,884,678	1,354,909
Cost of Sales — Engineering Services	217,233	227,186
Total Cost of Sales	2,101,911	1,582,095
Gross Profit	930,165	806,958
Operating Expenses:
Research and Development	1,752,560	1,751,397
Selling and Marketing	1,232,520	1,091,514
General and Administrative	2,593,384	2,165,341
Depreciation and Amortization	279,317	377,840
Impairment of Patents and Trademarks	104,716	73,423
Total Operating Expenses	5,962,497	5,459,515
Loss from Operations	-5,032,332	-4,652,557
Other Income (Expense)
Other Taxes	-83,419	-88,274
Foreign Exchange Loss	-2,713	-13,692
Loss on Sale of Assets	0	-40,352
Gain (Loss) on Debt Conversions and Extinguishment (Note 11)	29,262	-1,272,296
Loss on Derivative Valuation (Note 10)	-2,194,001	-3,575,278
Amortization of Senior Term Debt Discount (Note 11)	-393,525	0
Interest Expense	-192,130	-503,779
Total Other Income (Expense)	-2,836,526	-5,493,671
Loss from Before Provision for Income Taxes	-7,868,858	-10,146,228
Provision for Income Taxes (Note 13)	0	0
Net Loss	($7,868,858)	($10,146,228)
Basic and Diluted Loss per Share	($0.75)	($1.69)
Weighted-average Shares Outstanding Basic and Diluted	10,476,971	5,988,595

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Cash Flows from Operating Activities
Net Loss	($7,868,858)	($10,146,228)
Non-Cash Adjustments
Depreciation and Amortization	279,317	377,840
Impairment of Patents and Trademarks	104,716	73,423
Stock-Based Compensation Expense	260,747	159,272
Amortization and Write-off of Term Debt Discount	368,223	732,584
Interest Converted into Common Stock	0	222,032
Amortization of Term Debt Discount	25,302	25,302
Loss on Sale of Assets	0	40,352
Gain on Extinguishment of Debt for Note Conversions	-29,262
Amortization and Write-off of Debt Issuance Costs	26,819	257,692
Warrants Issued for Debt Extinguishment	0	97,913
Common Stock Issued for Services	395,205	0
Amortization of Software Development Costs	71,613	0
Loss on Derivative Valuation	2,194,001	3,575,278
(Increase) Decrease in Operating Assets
Accounts Receivable	-168,613	-44,320
Inventories	41,679	-266,446
Prepaid Expenses and Other Assets	-208,367	-37,993
Increase (Decrease) in Operating Liabilities
Accounts Payable	-237,006	-379,634
Accrued Expenses	1,216	34,592
Customer Deposits	-10,528	67,998
Unearned Revenue	13,701	39,700
Income and Other Taxes Payable	-40,693	54,365
Accrued Compensation	68,116	0
Accrued Interest	103,622	24,728
Net Cash Flows Used in Operating Activities	-4,609,050	-5,091,550
Cash Flows from Investing Activities
Purchases of Tooling and Equipment	-195,903	-145,929
Investments in Software Development	-618,790	-240,561
Investments in Patents and Trademarks	-86,647	-72,704
Net Cash Used in Investing Activities	-901,340	-459,194
Cash Flows from Financing Activities
Proceeds from Exercise of Warrants	2,682,669	56,250
Issuance of Common Stock	0	8,050,000
Repayment of Capital Leases	-24,670	-55,733
Direct Offering Associated Costs	0	-1,204,779
Net Change in Line of Credit	112,500	-112,500
Repayment of Long-Term Debt and Notes Payable	-345,942	-2,137,983
Proceeds from Senior Convertible Debt	3,000,000	1,000,000
Issuance Costs on Senior Convertible Debt	-139,340	-183,809
Proceeds from Notes Payable	0	382,884
Net Cash Flows Provided by Financing Activities	5,285,217	5,794,330
Net Increase (Decrease) in Cash and Cash Equivalents	-225,173	243,586
Cash and Cash Equivalents — Beginning of Period	310,140	66,554
Cash and Cash Equivalents — End of Period	84,967	310,140
Supplemental Disclosures
Interest Paid	88,508	230,112
Common Stock Issued For Services during 2014, Classified as Prepaid Expense	564,873	0
Conversion of Accrued Interest into Common Stock	0	1,076,250
Warrant Derivative Liability of Common Stock Offering and Debt Conversions	0	8,236,786
Conversion of Accrued Compensation and Term Debt into Common Stock	625,000	2,882,333
Unamortized Discount Upon Conversion of Term Debt	222,580	0
Reclassification of Derivative Liability to Paid-In Capital upon Note Conversions and Warrant Exercises	2,627,666	0
Discount on senior convertible debt attributed to embedded conversion price adjustment option	1,938,988	0
Warrants granted for senior convertible debenture issuance costs	$0	$66,603

Summary_of_Significant_Account

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 1 — Summary of Significant Accounting Policies
	Operations
	Vuzix Corporation (the Company) was formed in 1997 under the laws of the State of Delaware and maintains its corporate offices in Rochester, New York. The Company is engaged in the design, manufacture, marketing and sale of devices that are worn like eyeglasses and which feature built-in video screens that enable the user to view video and digital content, such as movies, computer data, the Internet or video games. Our products (known commercially as “Video Eyewear”) are used to view high resolution video and digital information from portable devices, such as cell phones, portable media players, gaming systems and laptop computers and from personal computers. Our products provide the user with a virtual viewing experience that emulates viewing a large screen television or desktop computer monitor practically anywhere, anytime.
	Principles of Consolidation
	The consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, Vuzix Europe. All significant inter-company transactions have been eliminated.
	Segment Data, Geographic Information and Significant Customers
	The Company is not organized by market and is managed and operated as one business. A single management team that reports to the chief operating decision maker comprehensively manages the entire business. The Company does not operate any material separate lines of business or separate business entities. Accordingly, the Company does not accumulate discrete information, other than product revenue and material costs, with respect to separate product lines and does not have separately reportable segments as defined by FASB ASC Topic 280, “Disclosures about Segments of an Enterprise and Related Information,”
	Shipments to customers outside of the United States approximated 43% and 36% of sales in 2014 and 2013, respectively. No single international country represented more than 10% of revenues. The Company does not maintain significant amounts of long-lived assets outside of the United States other than tooling held by its third party manufacturers, primarily in China.
	The Company has at times had a concentration of sales to the U.S. government, they amounted to approximately 10% and 17% of sales in 2014 and 2013, respectively. Accounts receivable from the U.S. government accounted for 6% and 79% of accounts receivable at December 31, 2014 and 2013, respectively.
	Foreign Currency Transactions
	The British Pound is the functional currency of the Company’s foreign subsidiary. Gains and losses arising upon settlement of foreign currency denominated transactions or balances are included in the determination of net loss.
	Use of Estimates
	The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at year end and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
	Concentration of Credit Risk
	The Company maintains its cash in bank deposit accounts, which at times may exceed federally insured limits.
	Cash and Cash Equivalents
	The Company’s cash received is applied against its revolving line of credit on a periodic basis based on projected monthly cash flows, reducing interest expense. Cash and cash equivalents can include highly liquid investments with original maturities of three months or less.
	Fair Value of Financial Instruments
	The Company’s financial instruments primarily consists of cash and cash equivalents, accounts receivable, accounts payable, lines of credit, long-term debt and capital leases, customer deposits, accrued expenses, and income taxes payable.
	As of the consolidated balance sheet date, the estimated fair values of the financial instruments were not materially different from their carrying values as presented due to both the short maturities of these instruments and that the interest rates on borrowing approximate those that would have been available for loans for similar remaining maturity and risk profiles.
	Accounts Receivable
	The Company carries its trade accounts receivable at invoice amount less an allowance for doubtful accounts. The Company establishes an allowance for uncollectible trade accounts receivable based on the age of outstanding invoices and management’s evaluation of collectability of outstanding balances. These provisions are established when the aging of outstanding amounts exceeds allowable terms and are re-evaluated at each quarter end for adequacy. In determining the adequacy of the provision, the Company considers known uncollectible or at risk receivables. There was no allowance for doubtful accounts as of December 31, 2014 and 2013. The Company does not accrue interest on past due accounts receivable unless it goes into collection.
	Inventories
	Inventories are valued at the lower of cost or market using the weighted average first-in, first-out method. The Company includes direct overhead costs in its inventory valuation costing. The Company records provisions for excess, obsolete or slow moving inventory based on changes in customer demand, technology developments or other economic factors. The Company’s products have product life cycles that range on average from two to three years currently. At both the product introduction and product discontinuation stage, there is a higher degree of risk of inventory obsolescence. The provision for obsolete and excess inventory is evaluated for adequacy at each quarter end. The estimate of the provision for obsolete and excess inventory is partially based on expected future product sales, which are difficult to forecast for certain products.
	Revenue Recognition
	The Company recognizes revenue from product sales in accordance with FASB ASC Topic 605 “Revenue Recognition”. Product sales represent the majority of the Company’s revenue. The Company recognizes revenue from these product sales when persuasive evidence of an arrangement exists, delivery has occurred, the sale price is fixed or determinable, and collectability is reasonably assured. The Company sells its products on terms which transfer title and risk of loss at a specified location, typically shipping point. Accordingly, revenue recognition from product sales occurs when all factors are met. If these conditions are not met, the Company will defer revenue recognition until such time as these conditions have been satisfied. The Company collects and remits sales taxes in certain jurisdictions and reports revenue net of any associated sales taxes. The Company also sells certain products through distributors who are granted limited rights of return for stock balancing against purchases made within a prior 90 day period, including price adjustments downwards that the Company implements on any existing inventory. The provision for product returns and price adjustments is assessed for adequacy both at the time of sale and at each quarter end and is based on recent historical experience and known customer claims and was not material as of December 31, 2014 or 2013.
	Revenue from any engineering consulting and other services is recognized at the time the services are rendered. The Company accounts for its longer-term development contracts, which to date have all been firm fixed-priced contracts, on the percentage-of-completion method, whereby income is recognized as work on contracts progresses, but estimated losses on contracts in progress are charged to operations immediately. The percentage-of-completion is determined using the cost-to-cost method. Amounts are generally billed on a monthly basis. To date all such contracts have been less than one calendar year in duration.
	The Company recognizes software license revenue under ASC 985-605 “Software Revenue Recognition” and under ASC 605-25 “Revenue Arrangements with Multiple Deliverables”, and related interpretations, as amended.
	Licensed software may be sold as a stand-alone element, with other software elements, or in conjunction with hardware products. When the Company’s products consists of more than one element, it is considered to be a multiple element arrangement (MEA). When sold as a stand-alone element, the revenue is recognized upon shipment as discussed above. When sold as part of a MEA, revenue from the licensed software is recognized when the product and embedded software is shipped to the customer.
	For either a single element transaction or a MEA, the Company allocates consideration to all deliverables based on their relative stand-alone selling prices. Amendments to ASC 605-25, which became effective January 1, 2011, establish a hierarchy to determine the stand-alone selling price as follows:
		·	Vendor Specific Objective Evidence of the fair value (VSOE),
		·	Third Party Evidence (TPE)
		·	Best Estimate of the Selling Price (ESP)
	Sales which constitute a MEA are accounted for by determining if the elements can be accounted for as separate accounting units, and if so, by applying values to those units, per the hierarchy above. If VSOE is not available, management estimates the fair selling price using historical pricing for similar items, in conjunction with current pricing and discount policies.
	Revenue from licensed software is recognized upon shipment and in accordance with industry-specific software recognition accounting guidance. Software updates that will be provided free of charge are evaluated on a case-by-case basis to determine whether they meet the definition of an upgrade and create a multiple element arrangement. The consideration allocated to the unspecified software upgrade rights and non-software services is deferred and recognized rateably over the 24-month estimated life of the devices. The Company’s BESP for the unspecified software upgrade right and non-software services is $25 per unit for the M100 Smart Glass.
	Fees charged to customers for post-contract Technical Support are recognized ratably over the term of the contract. Costs related to maintenance obligations are expensed as incurred.
	Unearned Revenue
	These amounts represent deferred revenue against unfulfilled deliverables of multiple-element products, including unspecified post-delivery support and software updates.
	Tooling and Equipment
	Tooling and equipment are stated at cost. Depreciation of tooling and equipment is provided for using the straight-line method over the following estimated useful lives:
	Computers and Software	3 years
	Manufacturing Equipment	5 years
	Tooling	3 years
	Furniture and Equipment	5 years
	Repairs and maintenance costs are expensed as incurred. Asset betterments are capitalized.
	Patents and Trademarks
	The Company capitalizes the costs of obtaining its patents and registration of Trademarks. Such costs are accumulated and capitalized during the filing periods, which can take several years to complete. Successful applications that result in the granting of a patent or trademark are then amortized over 15 years on a straight-line basis. Unsuccessful applications are written off and expensed in the fiscal period where the application is abandoned or discontinued.
	Software Development Costs
	The Company capitalizes the costs of obtaining its software once technological feasibility has been determined by management. Such costs are accumulated and capitalized and projects can take several years to complete. Unsuccessful or discontinued software projects are written off and expensed in the fiscal period where the application is abandoned or discontinued. Costs incurred internally in researching and developing a computer software product are charged to expense until technological feasibility has been established for the product. Once technological feasibility is established, all software costs are capitalized until the product is available for general release to customers. Judgment is required in determining when technological feasibility of a product is established. Once the product is available for general release, accumulated costs are amortized over the life of the asset. The amortization of these costs is included in cost of revenue over the estimated life of the products, which currently is estimated as 3 years using a straight-line basis.
	Long-Lived Assets
	The Company regularly assesses all of its long-lived assets for impairment when events or circumstances indicate their carrying amounts may not be recoverable, in accordance with FASB ASC Topic 360-10, “Accounting for the Impairment or Disposal of Long-Lived Assets.” In 2014, an impairment charge of $104,716 was recorded related to abandoned patents and trademarks. In 2013, an impairment charge of $73,423 was recorded related to abandoned patents and trademarks.
	Research and Development
	Research and development costs, are expensed as incurred consistent with the guidance of FASB ASC Topic 730, “Research and Development,” and include employee related costs, office expenses, third party design and engineering services, and new product prototyping costs. Costs incurred internally in researching and developing a computer software product are charged to expense until technological feasibility has been established for the product.
	Shipping and Handling Costs
	Amounts charged to customers and costs incurred by the Company related to shipping and handling are included in net sales and cost of goods sold, respectively, in accordance with FASB ASC Topic 605-45, “Revenue Recognition – Principal Agent Consideration”, “Accounting for Shipping and Handling Fees and Costs.”
	Provision for Future Warranty Costs
	The Company provides for the estimated returns under warranty and the costs of fulfilling our obligations under product warranties at the time the related revenue is recognized. The Company estimates the costs based on historical and projected product failure rates, historical and projected repair costs, and knowledge of specific product failures (if any). The specific warranty terms and conditions vary depending upon the country in which we do business, but generally include parts and labor over a period generally ranging from one to two years from the date of product shipment. The Company provides a reserve for expected future warranty returns at the time of product shipment or produces over-builds to cover replacements. We regularly reevaluate our estimates to assess the adequacy of the recorded warranty liabilities and adjust the amounts as necessary each quarter end and is based on historical experience of warranty claims and costs.
	Customer Deposits
	Customer deposits represents money the Company received in advance of providing a product or engineering services to a customer. All such deposits are short term in nature as the Company delivers the product, unfulfilled portions or engineering services to the customer before the end of its next annual fiscal period. These deposits are credited to the customer against product deliveries or at the completion of the customer’s order.
	Advertising
	Advertising costs are expensed as incurred and recorded in “Selling and Marketing” in the Consolidated Statements of Operations. Advertising expense for the years ended December 31, 2014 and 2013 amounted to $192,181 and $231,552, respectively.
	Income Taxes
	The Company accounts for income taxes in accordance with FASB ASC Topic 740-10, “Income Taxes.” Accordingly, the Company provides deferred income tax assets and liabilities based on the estimated future tax effects of differences between the financial and tax bases of assets and liabilities based on currently enacted tax laws. A valuation allowance is established for deferred tax assets in amounts for which realization is not considered more likely than not to occur.
	The Company reports any interest and penalties accrued relating to uncertain income tax positions as a component of the income tax provision.
Earnings Per Share
Basic earnings per share is computed by dividing the net (loss) income less accrued dividends on any outstanding preferred stock by the weighted average number of common shares outstanding for the period. Diluted earnings per share calculations reflect the assumed exercise of all dilutive employee stock options and warrants applying the treasury stock method promulgated by FASB ASC Topic 260, “Earnings Per Share” and the conversion of any outstanding convertible preferred shares or notes payable that are-in-the-money, applying the as-if-converted method. However, if the assumed exercise of stock options and warrants and the conversion of any preferred shares or convertible notes payable are anti-dilutive, basic and diluted earnings per share are the same for all periods. As a results of the net loss generated in 2014 and 2013 all outstanding instruments would be antidilutive. As of December 31, 2014 and 2013, there were 7,012,767 and 7,362,293 respectively, of common stock share equivalents potentially issuable under convertible debt agreements, options, and warrants that could potentially dilute basic earnings per share in the future. See Note 22 for details of dilutive and potentially dilutive securities issued after December 31, 2014.
Stock-Based Employee Compensation
The Company accounts for share-based compensation to employees and directors in accordance with FASB ASC Topic 718 “Compensation Stock Expense,” which requires that compensation expense be recognized in the consolidated financial statements for share-based awards based on the grant-date fair value using a Black-Scholes valuation model of those awards. The Company uses the fair market value of our common stock on the date of each option grant based on market price of the Company’s common shares. Stock-based compensation expense includes an estimate of forfeitures and is recognized over the requisite service periods of the awards on a straight-line or graded vesting basis, which is generally commensurate with the vesting term. Stock-based compensation expense associated with stock option grants for the years ending December 31, 2014 and 2013 was $260,747 and $159,272, respectively.
The Company issues new shares upon stock option exercises. Please refer to Note 16 Stock Option Plans, for further information.
Derivative Liability and Fair Value Measurements
FASB ASC Topic 820, “Fair Value Measurements and Disclosures” defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements. ASC 820 clarifies that fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. ASC 820 permits an entity to measure certain financial assets and financial liabilities at fair value with changes in fair value recognized in earnings each period. In accordance with ASC 815-10-25, we measured the derivative liability using a Lattice pricing model at their issuance date and subsequently they are remeasured. Accordingly, at the end of each quarterly reporting date the derivative fair market value is remeasured and adjusted to current market value. Derivatives that have more than one year remaining in their life are shown as long term derivative liabilities.
Significant unobservable inputs are used in the fair value measurement of the Company’s derivative liability. The primary input factors driving the economic or fair value of the derivative liabilities related to the warrants and convertible notes are the stock price of the Company’s shares, the price volatility of the shares, reset events, and exercise behavior. An important valuation input factor used in determining fair value was the expected volatility of observed share prices and the probability of projected resets in warrant exercise and note conversion prices from financing events before each security’s maturity. For exercise behavior the Company assumed that without a target price of 2 times the projected reset price or higher that the holders of the warrants and convertible notes would hold to maturity. In determining the fair value of the derivatives it was assumed that the Company’s business would be conducted as a going concern and that holding to maturity was reasonable. Further the January 2, 2015 Series A Preferred financing reduced the expected probably to near zero for price resets from financing events.
ASC 820 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value. Level 1 inputs are quoted prices in active markets for identical assets or liabilities. Level 2 inputs are inputs other than quoted prices included in Level 1 that are directly or indirectly observable for the asset or liability. Such inputs include quoted prices in active markets for similar assets and liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability, or inputs derived principally from or corroborated by observable market data by correlation or other means. Level 3 inputs are unobservable inputs for the asset or liability. Such inputs are used to measure fair value when observable inputs are not available.
Recent Accounting Pronouncements
In May 2014, the Financial Accounting Standards Board issued Accounting Standards Update No. 2014-09 ("ASU 2014-09"), Revenue from Contracts with Customers, an updated standard on revenue recognition. ASU 2014-09 provides enhancements to the quality and consistency of how revenue is reported while also improving comparability in the financial statements of companies reporting using International Financial Reporting Standards and GAAP. The core principle of the new standard is for companies to recognize revenue to depict the transfer of goods or services to customers in amounts that reflect the consideration to which the company expects to be entitled in exchange for those goods or services. The new standard also will result in enhanced disclosures about revenue, provide guidance for transactions that were not previously addressed comprehensively, and improve guidance for multiple-element arrangements. ASU 2014-09 will be effective in the first quarter of fiscal 2017 and may be applied on a full retrospective or modified retrospective approach. The Company is still currently evaluating the impact of implementation of this standard on its financial statements.
In August 2014, the FASB issued ASU 2014-15, ”Presentation of Financial Statements – Going Concern”, which provides guidance on determining when and how to disclose going-concern uncertainties in the financial statements. The new standard requires management to perform interim and annual assessments of an entity’s ability to continue as a going concern within one year of the date the financial statements are issued. An entity will be required to provide certain disclosures if conditions of events raise substantial doubt about the entity’s ability to continue as a going concern. The ASU applies to all entities and is effective for annual periods ending after December 15, 2016, and interim periods thereafter, with early adoption permitted. We are currently evaluating the impact of the adoption of ASU 2014-15 on our consolidated financial statements and have not yet determined when we will adopt the standard.
There are no other recent accounting pronouncements that are expected to have a material impact on the consolidated financial statements.

Inventories_Net

Inventories, Net	12 Months Ended
	Dec. 31, 2014
Inventory Disclosure [Abstract]
Inventories, Net	Note 2 — Inventories, Net
	Inventories consisted of the following:
		December 31,		December 31,
		2014		2013
	Purchased Parts and Components	$	1,251,224	$	1,094,250
	Work in Process		25,974		153,065
	Finished Goods		300,889		280,279
	Less: Reserve for Obsolescence		-666,138		-573,967
	Net	$	911,949	$	953,627

Tooling_and_Equipment_Net

Tooling and Equipment, Net	12 Months Ended
	Dec. 31, 2014
Property, Plant and Equipment, Net [Abstract]
Tooling and Equipment, Net	Note 3 — Tooling and Equipment, Net
	Tooling and equipment consisted of the following:
		December 31,		December 31,
		2014		2013
	Tooling and Manufacturing Equipment	$	1,374,751	$	1,748,006
	Computers and Software		581,472		645,429
	Furniture and Equipment		607,327		749,233
		$	2,563,550	$	3,142,668
	Less: Accumulated Depreciation		-2,146,585		-2,696,339
	Net	$	416,965	$	446,329
	Total depreciation expense for tooling and equipment for the years ending December 31, 2014 and 2013 was $225,267 and $322,861, respectively.

Patents_and_Trademarks_Net

Patents and Trademarks, Net	12 Months Ended
	Dec. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]
Patents and Trademarks, Net	Note 4 — Patents and Trademarks, Net
		December 31,		December 31,
		2014		2013
	Patents and Trademarks	$	697,591	$	777,593
	Less: Accumulated Amortization		-274,102		-281,985
	Net	$	423,489	$	495,608
	Total amortization expense for patents and trademarks for the years ending December 31, 2014 and 2013 it was $54,050 and $54,979, respectively. The estimated aggregate annual amortization expense for each of the next five fiscal years is approximately $50,000. We recorded an impairment charge of $104,716 representing cost of $166,500, less accumulated amortization of $61,784 for the year ending December 31, 2014. We recorded an impairment charge of $73,423 representing cost of $98,788, less accumulated amortization of $25,375 for the year ending December 31, 2013 regarding our abandoned patents and trademarks.

Software_Development_Costs_Net

Software Development Costs, Net	12 Months Ended
	Dec. 31, 2014
Research and Development [Abstract]
Software Development Costs, Net	Note 5 — Software Development Costs, Net
		December 31,		December 31,
		2014		2013
	Software Development Costs	$	859,351	$	240,561
	Less: Accumulated Amortization		-71,613		—
	Net	$	787,738	$	240,561
	Total amortization expense for capitalized software development costs for the years ending December 31, 2014 was $71,613 and $-0- for 2013. These costs are being amortized over 3 years. The software was completed in September 2014. No amortization was recorded in 2013 because the related software project was not completed as of December 31, 2013. The estimated aggregate annual amortization expense for each of the next two fiscal years is approximately $286,000, and approximately $215,000 in the following year.

Debt_Issuance_Costs

Debt Issuance Costs	12 Months Ended
	Dec. 31, 2014
Debt Disclosure [Abstract]
Debt Issuance Cost	Note 6 — Debt Issuance Costs
	Debt issuance costs consist principally of legal and accounting fees incurred related to the Senior Convertible Note Financing dated June 3, 2014.
		December 31,		December 31,
		2014		2013
	Debt Issuance Costs	$	139,340	$	—
	Less: Accumulated Amortization		-26,819		—
	Total	$	112,521	$	—
	The estimated aggregate annual amortization expense for each of the next two fiscal years is approximately $46,000 and approximately $21,000 in the following fiscal year.

Line_of_Credit

Line of Credit	12 Months Ended
	Dec. 31, 2014
Line Of Credit Facility [Abstract]
Lines Of Credit	Note 7 — Line of Credit
	The Company has available a $112,500 line of credit with interest payable at the bank’s prime rate plus 1%. The line is unsecured and personally guaranteed by an officer of the Company. The outstanding balance on this line of credit amounted to $112,500 and $-0- at December 31, 2014 and 2013, respectively.

Notes_Payable

Notes Payable	12 Months Ended
	Dec. 31, 2014
Notes Payable [Abstract]
Notes Payable	Note 8 — Notes Payable
	Notes payable represent promissory notes payable by the Company.
		December 31,		December 31,
		2014		2013
	Note payable to officers and shareholders of the Company. Principal along with accrued interest is payable on demand and paid on December 31, 2014. The notes bear interest at 18.5% and secured by all the assets of the Company.	$	37,038	$	229,787
	Note payable secured by all the assets of Company and the guarantee of its President and CEO. The effective interest rate was 31%. The note was repaid in full during the year ended December 31, 2014.		—		37,383
	Note payable to an officer of the Company due on December 31, 2014. The note was secured by all the assets of the Company. The note was repaid in full during the year ended December 31, 2014.		—		11,297
		$	37,038	$	278,467
	A total of $32,209 and $61,130 in accrued interest was paid during the years ending December 31, 2014 and 2013 respectively, to officers and stockholders related to various notes described above.

Accrued_Expenses

Accrued Expenses	12 Months Ended
	Dec. 31, 2014
Payables and Accruals [Abstract]
Accrued Expenses	Note 9 — Accrued Expenses
	Accrued expenses consisted of the following:
		December 31,		December 31,
		2014		2013
	Accrued Wages and Related Costs	$	101,445	$	91,385
	Accrued Compensation		428,786		360,670
	Accrued Professional Services		45,000		69,500
	Accrued Warranty Obligations		39,624		31,619
	Accrued Interest		75,471		36,935
	Other Accrued Expenses		8,741		1,090
	Total	$	699,067	$	591,199
	Included in the above accrued compensation amounts owed to officers of the Company for services rendered that remain outstanding. These amounts are not subject to a fixed repayment schedule and they bear interest at a rate of 8% per annum, compounding monthly. The amounts were $393,536 as of December 31, 2014 and $360,670 as of December 31, 2013. The related interest amounts included in Accrued Interest were $62,081 and $28,173 respectively at December 31, 2014 and December 31, 2013.
	The Company has warranty obligations in connection with the sale of certain of its products. The warranty period for its products is generally one year except in European countries where it is two years. The costs incurred to provide for these warranty obligations are estimated and recorded as an accrued liability at the time of sale. The Company estimates its future warranty costs based on product-based historical performance rates and related costs to repair.
	The changes in the Company’s accrued warranty obligations for the years ended December 31, 2014 and 2013 were as follows:
	Accrued Warranty Obligations at December 31, 2012	$	93,788
	Reductions for Settling Warranties		-74,287
	Warranty Issued During Year		12,118
	Accrued Warranty Obligations at December 31, 2013		31,619
	Reductions for Settling Warranties		-96,460
	Warranty Issued During Year		104,465
	Accrued Warranty Obligations at December 31, 2014	$	39,624

Derivative_Liability_and_Fair_

Derivative Liability and Fair Value Measurements	12 Months Ended
	Dec. 31, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Liability and Fair Value Measurements	Note 10 – Derivative Liability and Fair Value Measurements
	The Company recognized a derivative liability for the warrants to purchase shares of its common stock issued in connection with the equity offering and related debt conversions on August 5, 2013. These warrants have a cashless exercise provision and an exercise price that is subject to adjustment in the event of subsequent equity sales at a lower purchase price (subject to certain exceptions) along with full-ratchet anti-dilution provisions. In accordance with ASC 815-10-25, we measured the derivative liability using a Monte Carlo Options Lattice pricing model at their issuance date and subsequently remeasured the liability on each reporting date.
	Accordingly, at the end of each quarterly reporting date the derivative fair market value is remeasured and adjusted to current market value. As at December 31, 2014 and 2013 a total of 4,730,992 and 6,008,516 warrants were outstanding that contained a full-ratchet anti-dilution provision.
	The Company recognized a derivative liability during the year ended December 31, 2014 for the $3,000,000 of senior convertible notes with a conversion price that is subject to adjustment in the event of subsequent equity sales at a lower purchase price (subject to certain exceptions). In accordance with ASC 815-10-25, we measured the derivative liability of this embedded conversion option using a Monte Carlo Options Lattice pricing model at the June 3, 2014 issuance date as $1,938,988. The value of the derivative liability at issuance was recorded as a discount against the notes in the Long-Term Debt section of the balance sheet. Accordingly, at the end of each quarterly reporting date the derivative fair market value is remeasured and adjusted to current market value.
	The Company has adopted ASC Topic 820 for financial instruments measured at fair value on a recurring basis. ASC Topic 820 defines fair value, establishes a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements.
	Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 establishes a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include:
	-      Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;
	-      Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
	-      Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
	We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at December 31, 2014:
		Total			(Level 1)			(Level 2)		Level (3)
	Assets	$	—		$	—		$	—	$	—
	Total assets measured at fair value		—			—			—		—
	Liabilities
	Note Conversion Feature Liability in 2014		2,806,942			—			—		2,806,942
	Warrant Liability		10,734,196			—			—		10,734,196
	Total liabilities measured at fair value (Long-Term)	$	13,541,138		$	—		$	—	$	13,541,138
	We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at December 31, 2013
		Total			(Level 1)			(Level 2)		Level (3)
	Assets	$	—		$	—		$	—	$	—
	Total assets measured at fair value		—			—			—		—
	Liabilities
	Warrant Liability		12,035,816			—			—		12,035,816
	Total liabilities measured at fair value (Long-Term)	$	12,035,816		$	—		$	—	$	12,035,816
	Fair value – December 31,2012	$	—
	Warrants issue during period		9,067,283
	Reclassification (reset expiration) of warrant liabilities to Additional Paid-in Capital		-526,245
	Reclassification of warrant exercises to Additional Paid-in Capital		-80,500
	Change in fair value for the period of warrant derivative liability		-3,575,278
	Fair value – December 31, 2013		12,035,816
	Reclassification of warrant exercises to Additional Paid-in Capital		-2,127,405
	Change in fair value for the period of warrant derivative liability		825,786
	Convertible debt issued with an embedded conversion price adjustment provision		1,938,988
	Extinguishment of liability upon conversion of debt		-500,261
	Change in fair value of debt conversion price adjustment for the period		1,368,215
	Fair value – December 31, 2014	$	13,541,138
	For period ending December 31, 2014, the Monte Carlo Options Lattice pricing model was used to estimate the fair value of the embedded conversion option on the convertible notes issued during this period. The following summary table shows the assumptions used to compute the fair value of the embedded conversion option when granted at issuance and as of December 31, 2014:
		December 31, 2014				At Issuance – June 3,
						2014
	Assumptions for Pricing Model:
	Expected term in years		2.67				3
	Volatility range for years 1 to 5		81	%			57	%
	Expected annual dividends		None				None
	Value of convertible debt price adjustment:
	Fair value of debt embedded conversion price adjustment option	$	2,806,942			$	1,938,988
	The Monte Carlo Options Lattice pricing model was used to estimate the fair value of warrants outstanding:
		December 31,			December 31,			At Issuance
		2014			2013			Aug 5, 2013
	Assumptions for Pricing Model:
	Expected term in years		3.47 to 4.04			4.2 to 4.6			4.62 to 5.0
	Volatility range for years		72 to 81%			56 to 62%			61 to 110%
	Risk-free interest rate		0.93 to 1.83%			1.75%			0.77 to 1.41%
	Expected annual dividends		None			None			None
	Value of warrants outstanding:
	Fair value of warrants	$	10,734,196		$	12,035,816		$	9,067,283

LongTerm_Debt

Long-Term Debt	12 Months Ended
	Dec. 31, 2014
Debt Disclosure [Abstract]
Long-Term Debt	Note 11 — Long-Term Debt
	Long-term debt consisted of the following at December 31:
		December 31,		December  31,
		2014		2013
	Note payable for research and development equipment. The principal is subject to a fixed semi-annual repayment schedule commencing October 31, 2013 over 48 months. The note carries a 0% interest rate.		186,131		256,727
	The note carries a 0% interest, but imputed interest has been accrued based on a 12% discount rate and is reflected as a reduction in the principal.		-46,399		-71,701
	Note payable for which the principal and interest is subject to a fixed blended repayment schedule of 36 months, commencing July 15, 2013. The loan bears interest at 12% per annum and is secured by a subordinated position in all the assets of the Company.		50,874		84,790
	Convertible, Senior Secured Notes payable. The principal is due June 3, 2017 and no principal payments are required. The notes carry a 5% interest, payable upon the note’s maturity. Both the interest plus accrued interest is convertible into shares of the Company’s common shares at $2.25, subject to normal adjustments. The notes are secured by a first security position in all the assets of the Company. Most of the notes are held by existing stockholders of the Company.		2,375,000		—
	Unamortized debt discount related to derivative liability associated with above notes’ conversion price that is subject to adjustment in the event of subsequent equity sales at a lower purchase price (subject to certain exceptions). Upon issuance on June 3, 2014 the discount was $1,938,988. As of December 31, 2014 a net of $368,223 of the discount was recognized as interest expense and $222,580 was reversed due to conversions of the notes into shares of common stock. A net gain of $29,262 was recorded on the conversion of $625,000 in notes for the year ending December 31, 2014 resulting from the extinguishment of the debt and the related derivative liability.		-1,348,185		—
		$	1,217,421	$	269,816
	Less: Amount Due Within One Year		-128,425		-99,320
	Amount Due After One Year	$	1,088,996	$	170,496
	The calendar year aggregate maturities for all long-term borrowings exclusive of discounts as of December 31, 2014 are as follows:
	Total Aggregate Maturity For Period	Amounts
	2015	$	153,727
	2016		83,278
	2017		2,375,000
	Total Required Principal Payments Exclusive of Debt Discounts		2,612,005
	Total Unamortized Debt Discounts		-1,394,584
	Total Net Long-Term Borrowings as of December 31, 2014	$	1,217,421
	On June 3, 2014, we entered into and closed a securities purchase agreement (the “June 2014 Purchase Agreement”) with various accredited investors (the “June 2014 Investors”) pursuant to which we issued and sold to the June 2014 Investors a total of $3,000,000 principal amount of 5% Senior Secured Convertible Notes (the “June 2014 Notes”). The Company granted the June 2014 Investors a first priority security interest in all of the present and future assets of the Company and its subsidiaries, including the equity interests of its subsidiaries. There are no scheduled payments on the June 2014 Notes, which are due on June 3, 2017, prior to maturity. Interest on the June 2014 Notes accrues at the rate of 5% per year, compounded annually, and is payable at maturity in cash, or (provided certain conditions are met) in shares of common stock valued at the then effective conversion price. The June 2014 Notes are convertible into common stock at an initial conversion price of $2.25 per share, subject to adjustment in the event of stock splits, stock dividends, and similar transactions, and, and under their initial terms, in the event of subsequent sales of common stock or securities convertible or exercisable for common stock, at a price per share lower than the then effective conversion price, subject to certain exceptions. The Company is not permitted to prepay any portion of the principal amount of the June 2014 Notes without the prior written consent of the June 2014 Investors unless certain conditions are met.
	Pursuant to a registration rights agreement, dated June 3, 2014, between the Company and the June 2014 Investors, the Company agreed to file a registration statement, relating to the resale of common stock issuable upon conversion of the June 2014 Notes and payable as interest on the June 2014 Notes. The Company filed such registration statement on July 2, 2014, and the registration statement was declared effective by the Securities and Exchange Commission on July 10, 2014.
	Since these notes were originally issued to December 31, 2014, a total of $625,000 of the June 2014 Notes were converted into 277,777 shares of common stock.
	In connection with the sale of the TDG Assets in June 2012, certain of the Company’s lenders entered into Loan Modification and Consent agreements pursuant to which each consented to the sale, as required by the loan agreements between the Company and each such lender, and released their security interests in the TDG Assets sold. Pursuant to a Loan Modification and Consent Agreement regarding the Company’s Convertible, Senior Secured Term Debt Loan, which was in default at the time of the sale, the Company paid this Senior Lender $4,450,000 in reduction of the obligations of the Company to the Senior Lender. The obligation of the Company to repay the remaining amount due to the Convertible Senior Secured Term Debt Lender, $619,122 was represented by a new note in that amount. This new note carried an interest rate of 13.5%, to be paid monthly. The principal amount of the note was to be repaid over 15 months, with equal principal payments commencing on October 15, 2012. The Company did not make any of its required principal payments. The note plus accrued interest was repaid in full on August 5, 2013.
	Pursuant to its original transaction with the holder of the Senior Secured Term Debt, the Company issued to that lender warrants to purchase up to 533,333 shares of common stock (the “Warrants”), at an exercise price of $7.47 per share, exercisable at any time prior to December 23, 2014. The fair value of these Warrants, $1,010,379 was reflected as a discount against the loan amount, but because of the loan’s restructuring and the early repayment of the principal resulting from the TDG Assets sale, the unamortized discount of $636,678 was fully expensed in the second quarter of 2012.
	Pursuant to the various other Loan Modification and Consent agreements, each secured term note payable holder agreed to defer further payments on their respective Note Payable due from the Company until July 15, 2013 after which the notes were to be repaid in 24 to 36 equal monthly installments.
	On March 27, 2013, and amended thereafter, the Company entered into several debt conversion agreements with the respective holders of $2,374,682 of the long-term debt reflected in table above. Pursuant to the agreements, each lender agreed to convert its outstanding secured promissory note, together with accrued interest thereon into shares of the Company’s common stock, subject to the closing of the Company’s proposed public stock offering, at a conversion price equal to the public offering price. In connection with the closing of the public offering on August 5, 2013, $1,755,570 of these loan amounts plus accrued interest were converted to shares of common stock and warrants and the remainder was repaid.
	On March 21, 2013, the Company entered into a Securities Purchase Agreement with Hillair Capital Management L.P. (Hillair), pursuant to which, on March 21, 2013, the Company issued to Hillair a $800,000 16% secured convertible debenture due March 21, 2018. The debenture bore interest at a rate of 16% per year, payable quarterly in cash or shares of common stock at the Company’s option. Commencing on February 1, 2014, the Company was required to redeem a certain amount under the debenture on a periodic basis in an amount equal to $200,000 on each of February 1, 2014, May 1, 2014 and August 1, 2014 and $50,000 on each of August 1, 2015, August 1, 2016, August 1, 2017 and March 21, 2018, until the debenture’s maturity date of March 21, 2018; payable in cash or common stock at our option subject to certain conditions. The debenture was convertible into shares of our common stock at a conversion price of $4.29 per share, subject to certain conversion price adjustments. In connection with the debenture issuance, the Company also issued to Hillair five-year warrants to purchase 186,480 shares of its common stock at an initial exercise price of $4.72 per share, which was subject to exercise price adjustments for only the first six months. Upon the closing of the public offering, the warrant exercise was reduced to $2.25. The warrants were reflected as a derivative liability on the balance sheet and recorded as a discount against the debenture. Upon the closing of the public offering on August 5, 2013, the debenture principal and accrued interest was repaid along with an early repayment penalty of $160,000, and the warrant exercise was reduced to $2.25.
	On July 15, 2013, the Company entered into a Securities Purchase Agreement with Hillair, pursuant to which the Company issued to Hillair a $200,000 senior secured convertible debenture due March 21, 2018, and (ii) a common stock purchase warrant to purchase up to 38,168 shares of our common stock at an initial exercise price of $5.24 per share, which is subject to exercise price adjustments for the first six months. The warrants may be exercised at any time on or after July 15, 2013 until March 21, 2018. The warrants were reflected as a derivative liability on the balance sheet and recorded as a discount against the debenture, The debenture was convertible into shares of common stock at a conversion price of $5.24 per share, subject to adjustments upon certain events. Interest on the Debenture accrued at the rate of 16% annually and was payable quarterly on February 1, May 1, August 1 and November 1, beginning on August 1, 2013, on any redemption, conversion and at maturity. Interest was payable in cash or at the Company’s option in shares of our common stock, provided certain conditions are met. Commencing on February 1, 2014, the Company would have been obligated to redeem a certain amount under the debenture on a periodic basis in an amount equal to $50,000 on each of February 1, 2014, May 1, 2014 and August 1, 2014 and $12,500 on each of August 1, 2015, August 1, 2016, August 1, 2017 and March 21, 2018, until the debenture’s maturity date of March 21, 2018. Upon the closing of the public offering on August 5, 2013, the debenture principal and accrued interest was repaid along with an early repayment penalty of $40,000, and the warrant exercise was reduced to $2.25.
	Upon closing of the debenture transaction, the Company retained Gentry Capital Advisors LLC (Gentry) as a financial advisor and agreed to pay Gentry a fee of $50,000 over a period of 4 months commencing upon the closing. The Company also issued to Gentry five-year warrants to purchase 20,000 shares of common stock at an exercise price of $4.72 per share. The fair value of these warrants upon grant was calculated as $66,603 and was reflected in the deferred debenture issuance costs. In connections with the issuance of the two debentures the Company incurred issuance costs which totaled $257,691, inclusive of the financial advisor’s warrant discussed above. These costs were amortized on a straight-line basis over the five year life of the debenture, until the debt was repaid on August 5, 2013, after which it was expensed and included in debt extinguishment costs for the year ended December 31, 2013.
	The Company used cash from the August 5, 2013 offering for the repurchases and cancellation of the two debentures. As a result of the two debt repayments above, the Company incurred a loss on debt extinguishment of $1,272,296 which also includes $240,637 of unamortized capitalized debt issuance costs and $685,965 of unamortized debt discounts which were written-off.

Capital_Lease_Obligations

Capital Lease Obligations	12 Months Ended
	Dec. 31, 2014
Capital Lease Obligations [Abstract]
Capital Lease Obligations	Note 12 — Capital Lease Obligations
	The Company maintains equipment held under capital lease obligations due in monthly installments of $2,049 including interest at rates of 26.71%. The related equipment is collateral to the leases. Final payments are due through September 2015.
		December 31,		December 31,
		2014		2013
	Total Principal Payments	$	16,882	$	41,552
	Less: Amount Due Within One Year		-16,882		-24,670
	Amount Due After One Year	$	—	$	16,882
	Annual requirements for retirement of the capital lease obligations are as follows:
		Amount
	2015	$	18,445
	Total Minimum Lease Payments	$	18,445
	Less: Amount Representing Interest		-1,563
	Present Value of Minimum Lease Payments	$	16,882
	The following is a summary of assets held under capital leases:
	December 31,	2014		2013
	Computers and Software	$	16,200	$	30,692
	Furniture and Equipment		35,083		35,083
		$	51,283		65,775
	Less: Accumulated Depreciation		-42,230		-52,275
	Net	$	9,053	$	13,500
	Depreciation expense related to the assets under capital lease amounted to $12,417 and $17,247 for years ended December 31, 2014 and 2013, respectively.

Income_Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Income Taxes	Note 13 — Income Taxes
	The Company files U.S. federal and various state and foreign tax returns.
	Pre-tax earnings consisted of the following for the years ended December 31, 2014 and 2013:
	December 31,	2014			2013
	Pre-Tax (Loss) Earnings
	U.S.	$	-7,868,858		$	-10,146,228
	Outside the U.S.		—			—
	Total Pre-Tax (Loss) Earnings	$	-7,868,858		$	-10,146,228
	The provision (benefit) for income taxes for the years ended December 31, 2014 and 2013 was as follows:
			2014			2013
	U.S. Income Taxes
	Current Provision	$	—		$	—
	Deferred Provision		—			—
	Income Taxes Outside the U.S.
	Current Provision		—			—
	Deferred Provision		—			—
	State Income Taxes
	Current Provision		—			—
	Deferred Provision		—			—
	Total Provision	$	—		$	—
	A reconciliation of the statutory U.S. federal income tax rate to the effective rates for the years ended December 31, 2014 and 2013 is as follows:
		2014				2013
	Federal Income Tax at Statutory Rate		34	%			34.4	%
	State Tax Provision, Net of Federal Benefit		0.2	%			0.5	%
	Foreign Income Taxed at Other Than 34%		0	%			-0.2	%
	Loss on Derivative Valuation		-11.1	%			-12.2	%
	Change in Rate Assumptions		0	%			41	%
	Other		-2.2	%			-0.3	%
	Effective Tax Rate		20.9	%			63.2	%
	Change in Valuations Allowance		-20.9	%			-63.2	%
	Net Effective Tax Rate		0	%			0	%
	Deferred tax assets (liabilities) for the years ended December 31, 2014 and 2013 consist of the following:
		2014			2013
	Deferred Tax Assets
	Net Operating Loss Carry-forwards		11,418,496			9,739,496
	Tax Credit Carry-forwards		1,433,229			1,466,429
	Other		876,606			486,497
	Total Deferred Tax Assets	$	13,728,331		$	11,692,422
	Deferred Tax Liabilities
	Other		614,027			226,344
	Net Deferred Tax Assets Before Valuation Allowance	$	13,114,304		$	11,466,078
	Valuation Allowance		-13,114,304			-11,466,078
	Net Deferred Tax Assets	$	—		$	—
	As of December 31, 2014, the Company has approximately $33.3 million in net operating loss carry-forwards and approximately $1.4 million of credit carry-forwards which will begin to expire in 2018 if not utilized.
	As the result of the assessment of the FASB ASC 740-10 (Prior Authoritative Literature: FASB Interpretation No. 48 (“FIN 48”), Accounting for Uncertainty in Income Taxes — An Interpretation of FASB Statement No. 109), the Company has no unrecognized tax benefits. By statute, tax years 2011-2014 are open to examination by the major taxing jurisdictions to which the Company is subject.
	FASB ASC 740 (Prior Authoritative Literature: SFAS No. 109, Accounting for Income Taxes), requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on differing treatment of items for financial reporting and income tax reporting purposes. The deferred tax balances are adjusted to reflect tax rates by tax jurisdiction, based on currently enacted tax laws, which will be in effect in the years in which the temporary differences are expected to reverse. In light of the historic losses of the Company, a 100% valuation allowance has been recorded to fully offset any benefit associated with the net deferred tax assets.

Capital_Stock

Capital Stock	12 Months Ended
	Dec. 31, 2014
Stockholders' Equity Note [Abstract]
Capital Stock	Note 14 — Capital Stock
	Preferred stock
	Shares of undesignated preferred stock may be issued in one or more series. The Board of Directors is authorized to establish and designate the different series and to fix and determine the voting powers and other special rights and qualifications. A total of 5,000,000 shares of preferred authorized are authorized as of December 31, 2014 and December 31, 2013. There were 0 shares issued or outstanding on December 31, 2014 and 2013. There were no preferred dividends owing as of December 31, 2014 or 2013. See Subsequent Event Note 22.
	Common Stock
	All per share amounts, outstanding shares, warrants, options and shares issuable pursuant to convertible securities for all periods reflect the Company’s 1-for-75 reverse stock split, which was effective February 6, 2013.
	On August 5, 2013, the Company consummated a public offering of 4,025,000 shares of common stock, and warrants to purchase up to an aggregate of 4,025,000 shares of common stock, at a public offering price of $2.00 per share and $0.0001 per warrant. The warrants have a per share exercise price of $2.25, are exercisable immediately, and expire 5 years from the date of issuance. Total gross proceeds from the public offering were $8,050,000, before underwriting discounts and commissions and other offering expenses of $1,358,641 payable by the Company. Upon the closing of this offering, the Company repaid $2,137,984 in term debt and $200,000 in early repayment penalties. Overall the Company netted approximately $4,350,000 from the public offering.
	Simultaneous with the closing of this public offering $2,316,007 in outstanding secured debt and accrued interest thereon, converted into common stock and warrants at a conversion price equal to the offering price of $2.00. Additionally $1,642,569 in outstanding long-term accrued compensation and accrued interest owed to our officers was converted into common stock and warrants at a conversion price equal to the offering price of $2.00.

Stock_Warrants

Stock Warrants	12 Months Ended
	Dec. 31, 2014
Stockholders' Equity Note [Abstract]
Stock Warrants	Note 15 — Stock Warrants
	The following table shows the various changes in warrants for the years December 31, 2014 and 2013.
		December 31,	December 31,
		2014	2013
	Warrants Outstanding, Beginning of Year	7,147,775	656,641
	Exercised During the Year	-1,285,746	-59,300
	Issued During the Year	—	6,551,654
	Forfeited During the Year	-625,369	-1,220
	Warrants Outstanding, End of Year	5,236,660	7,147,775
	The outstanding warrants as of December 31, 2014 expire from May 21, 2015 to August 5, 2018. The weighted average remaining term of the warrants is 3.6 years. The weighted average exercise price is $2.28 per share.
	A total of 206,420 warrants were re-priced to $2.25 from $4.72 and 38,168 warrants were re-priced to $2.25 from $5.24 upon the closing of the public offering on August 5, 2013.

Stock_Option_Plans

Stock Option Plans	12 Months Ended
	Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock Option Plans	Note 16 — Stock Option Plans
	The Company has the following Stock Option Plans (“Plans”) that allow for the granting of both statutory and incentive stock options or ISOs, which can result in potentially favorable tax treatment to the participant, and non-statutory stock options. The Company’s 2014 Equity Incentive Plan (the “2014 Plan”) was approved by the stockholders of the Company on June 26, 2014. The Company will no longer issue any options under the 2007 and 2009 Plans. The 2014 Plan has an “evergreen provision”, under which the maximum number of shares of common stock that may be issued under the 2014 Plan was initially 1,000,000 and shall automatically be increased each time the Company issues additional shares of common stock so that the total number of shares issuable hereunder shall at all times equal 10% of the then outstanding shares of common stock, unless in any case the Board of Directors adopts a resolution providing that the number of shares issuable under the 2014 Plan shall not be so increased.
	The exercise price per share subject to an option is determined by the administrator, but in the case of an ISO must not be less than the fair market value of a share of our common stock on the date of grant and in the case of a non-statutory stock option must not be less than 100% of the fair market value of a share of our common stock on the date of grant.
	Under the 2014 Plan, the Company may grant stock options, stock appreciation rights, performance awards of stock and/or cash, and stock awards of restricted stock.
		2007 Plan		2009 Plan		2014 Plan		Total
	Outstanding as of  December 31, 2014	57,209		120,842		542,500		720,551
	Available for future issuance under plan	—		—		457,500		457,500
	Totals authorized by plan	57,209		120,842		1,000,000		1,178,051
	The 2014 Plan gives the Board of Directors of the Company the ability to determine vesting periods for all stock incentives granted under the 2014 Plan, and allows option terms to be up to ten years from the original grant date. Employees’ incentive stock options must vest at a minimum rate of 20% per year over a five year period, commencing on the date of grant. Most vest ratably over four years commencing on the date of the option grant. In the case of directors, such options are granted annually and they expire ten years after the date of their grant and vest ratably, on a monthly basis, over the next 12 months. Non-employee directors have vesting of 50% immediately on grant and the balance vest ratably, on a monthly basis, over the next 12 months. Advisors or consultants can have vesting range from 100 percent of the option grants vesting immediately to ratably, on a monthly basis, up to 48 months.
	The following table summarizes stock option activity for the years ended December 31, 2014 and 2013:
				Weighted			Weighted Average
		Number of		Average			Remaining Life
		Shares		Exercise Price			(years)
	Outstanding at December 31, 2012	192,729		$	10.68			4.52
	Granted	45,000			2
	Exercised	—			—
	Expired or Forfeited	-23,211			2.71
	Outstanding at December 31, 2013	214,518		$	9.72			6.11
	Granted	548,000			2.63
	Exercised	-10,819			1.71
	Expired or Forfeited	-31,148			2.71
	Outstanding at December 31, 2014	720,551		$	4.46			8.56
	As of December 31, 2014, there were 257,786 options that were fully vested and exercisable at weighted average exercise price of $7.72 per share. The weighted average remaining contractual term on the vested options is 6.8 years.
	The unvested balance of 462,384 options as of December 31, 2014, are exercisable at a weighted average exercise price of $2.63 per share. The weighted average remaining contractual term on the vested options is 9.6 years.
	The aggregate intrinsic value of the options outstanding as of December 31, 2014 was approximately $268,000.
	The Black-Scholes-Merton option pricing model was used to estimate the fair value of share-based awards under FASB ASC Topic 718. The Black-Scholes-Merton option pricing model incorporates various and highly subjective assumptions, including expected term and expected volatility. For valuation purposes, stock option awards were categorized into two groups, stock option grants to employees and stock option grants to members of the Board of Directors.
	The expected term of options granted was estimated to be the average of the vesting term, historical exercise and forfeiture rates, and the contractual life of the option. The expected volatility at the grant date is estimated using historical stock prices based upon the expected term of the options granted. The risk-free interest rate assumption is determined using the rates for U.S. Treasury zero-coupon bonds with maturities similar to those of the expected term of the award being valued. Cash dividends have never been paid and are not anticipated to be paid in the foreseeable future. Therefore, the assumed expected dividend yield is zero.
	The following summary table shows the assumptions used to compute the fair value of stock options granted during 2014 and 2013 and their estimated value:
	December 31,	2014				2013
	Assumptions for Black-Scholes:
	Expected term in years		5.6 to 10 .0				10
	Volatility		118.6 to 119.7%				128.8	%
	Risk-free interest rate		1.70 to 2.42%				2.81	%
	Expected annual dividends		None				None
	Value of options granted:
	Number of options granted		548,000				45,000
	Weighted average fair value/share	$	2.63			$	$2.00
	Fair value of options granted	$	1,241,904			$	81,884
	FASB ASC Topic 718 requires pre-vesting option forfeitures at the time of grant to be estimated and periodically revised in subsequent periods if actual forfeitures differ from those estimates. Stock-based compensation expense is recorded only for those awards expected to vest using an estimated forfeiture rate based on historical pre-vesting forfeiture data.
	Unrecognized stock-based compensation expense was approximately $1,100,000 as of December 31, 2014, relating to a total of 462,765 unvested stock options under the Company’s stock option plans. This stock-based compensation expense is expected to be recognized over a weighted average period of approximately 2.1 years.

Commitments

Commitments	12 Months Ended
	Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
Commitments	Note 17 — Commitments
	The Company leases office and manufacturing space under operating leases that expires on September 30, 2015. It requires monthly payments of $4,200 plus insurance, taxes and common charges.
	Rent expense for the years ended December 31, 2014 and 2013 totaled $116,743 and $104,766, respectively.
	Future minimum payments required under operating lease obligations as of December 31, 2014 were as follows:
				Total Minimum
		2015		Lease Payments
		$	81,080	$	81,080
	For the lease agreements described above, the Company is required to pay the pro rata share of the real property taxes and assessments, expenses and other charges associated with these facilities.

Employee_Benefit_Plans

Employee Benefit Plans	12 Months Ended
	Dec. 31, 2014
Compensation and Retirement Disclosure [Abstract]
Employee Benefit Plans	Note 18 — Employee Benefit Plans
	The Company has a Section 401(k) Savings Plan which covers employees who meet certain age and length of service requirements. To date the plan is comprised of 100% employee deferrals.

Litigation

Litigation	12 Months Ended
	Dec. 31, 2014
Litigation Disclosure [Abstract]
Litigation	Note 19 — Litigation
	We are not currently involved in any pending legal proceeding or litigation.

Concentrations

Concentrations	12 Months Ended
	Dec. 31, 2014
Risks and Uncertainties [Abstract]
Concentrations	Note 20 — Concentrations
	For 2014 and 2013, sales to the U.S. government accounted for approximately 10% and 17%, respectively.
	Accounts receivable from the U.S. government accounted for 6%, and 79% of accounts receivable at December 31, 2014 and 2013, respectively.

Related_Party_Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2014
Related Party Transactions [Abstract]
Related Party Transactions	Note 21 — Related Party Transactions
	Pursuant to a debt conversion agreement of March 2013 and in connection with the closing of the public offering on August 5, 2013, two notes payable to an officer of the Company entire principal amounts plus accrued interest were converted into shares of common stock based on the offering price of $2.00 per share and warrants exercisable at $2.25 per share. Interest expense related to the note payable amounted to $32,507 for the period it was outstanding in 2013.
	On March 27, 2013, the Company entered into deferred compensation deferral and conversion option agreements with two officers, which agreements were subject to the closing of the Company’s public stock offering and which agreements were effective upon such closing on August 5, 2013. Pursuant to those agreements the officers each converted the entire long-term portion their deferred compensation amounts plus accrued interest in connection with the closing of the public offering on August 5, 2013 a total of $1,126,763 of their deferred compensation amounts plus accrued interest totaling $515,806 into shares of the Company’s common stock based on the offering price of $2.00 per share and warrants exercisable at $2.25 per share. Interest expense related to accrued current and long-term accrued compensation amounts to $0 and $107,209 for the years ended December 31, 2014 and 2013, respectively.

Subsequent_Events

Subsequent Events	12 Months Ended
	Dec. 31, 2014
Subsequent Events [Abstract]
Subsequent Events	Note 22 — Subsequent Events
	Series A Preferred Stock sale of $24,813,000 to Intel Corporation:
	On January 2, 2015 (the “Series A Closing Date”), we entered into and closed a Series A Preferred Stock Purchase Agreement (the “Series A Purchase Agreement”) with Intel Corporation (the “Series A Purchaser”), pursuant to which we issued and sold to the Series A Purchaser, an aggregate of 49,626 shares of the Company’s Series A Preferred Stock, at a purchase price of $500 per share, for an aggregate purchase price of $24,813,000 (the “Series A Private Placement”). Each share of Series A Preferred Stock is convertible, at the option of the Series A Purchaser, into 100 shares of the Company’s common stock (determined by dividing the Series A Original Issue Price of $500 by the Series A Conversion Price. The Series A Conversion Price is $5.00, subject to adjustment in the event of stock splits, dividends or other combinations). Total costs incurred connection with this offering were approximately $150,000.
	Each share of Series A Preferred Stock is entitled to receive dividends at a rate of 6% per annum, compounded quarterly and payable in cash or in kind, at the Company’s sole discretion. In the event of the liquidation, dissolution or winding up of the Company, each share of Series A Preferred Stock is entitled to a liquidation preference equal to one times (1x) the Series A Purchaser’s original per share purchase price, plus a right to receive an additional liquidation distribution together with the common stock holders pro rata on an as converted basis, but not in excess of $1,000 per share in the aggregate (subject to adjustment for accrued but unpaid dividends and in the event of stock splits, dividends or other combinations). Each share of Series A Preferred Stock is entitled to vote with the holders of the Company’s common stock on matters presented to its stockholders, and is entitled to cast such number of votes equal to the whole number of shares of common stock into which such shares of Series A Preferred Stock are convertible. The holders of record of the Series A Preferred Stock will be entitled to nominate and elect 2 directors to the Company’s Board of Directors (the “Board Election Right”), at least one of whom will be required to qualify as an “independent” director, as that term is used in applicable exchange listing rules. The Board Election Right with respect to the independent director will terminate on such date as the number of shares of Series A Preferred Stock then outstanding is less than 40% of the original amount purchased by the Series A Purchaser. The Board Election Right with respect to the second director shall terminate on such date as the number of shares of Series A Preferred Stock then outstanding is less than 20% of the original amount purchased by the Series A Purchaser. The Company also granted the Series A Purchaser the right to have a board observer at meetings of the Company’s Board of Directors and committees thereof.
	For as long as at least 25% (or 12,406 shares) of the Series A Preferred Stock is outstanding, the Company may not, without the consent of holders of at least 60% of the then outstanding shares of Series A Preferred Stock, take certain actions, including but not limited to: (i) liquidate, dissolve, or wind up the business and affairs of the Company; (ii) amend, alter or repeal any provision of its charter or bylaws in a manner that adversely effects the rights of the Series A Preferred Stock; (iii) create or issue any capital stock that is equal to or senior to the Series A Preferred Stock with respect to preferences; (iv) create or issue any debt security, subject to certain exceptions; (v) pay off any debt obligation prior to its stated maturity date; or (vi) enter into any stockholders rights plan or similar arrangement or take other actions that may limit actions that holders of a majority of the Series A Preferred Stock can take under Section 203 (“Section 203”) of the Delaware General Corporation Law, as well as such other customary provisions protecting the rights of the holder of the Series A Preferred Stock, as are outlined in the Certificate of Designation.
	The Series A Purchaser has the right to participate in any proposed issuance by the Company of its securities, subject to certain exceptions (the “Participation Right”). In the event the Series A Purchaser is not afforded the opportunity to exercise its Participation Right, the Series A Purchaser will have the right, but not the obligation, up to two times per calendar year, to acquire additional securities from the Company in such amount as is sufficient to maintain the Series A Purchaser’s ownership percentage in the Company, calculated immediately prior to such applicable financing, at a purchase price equal to the per share price of the Company’s securities in such applicable financing.
	In connection with the Series A Private Placement, the Company entered into an investor’s rights agreement (the “Rights Agreement”) with the Series A Purchaser, pursuant to which the Company agreed to file a “resale” registration statement with the Securities and Exchange Commission (the “SEC”) covering all shares of common stock issuable upon conversion of the Series A Preferred Stock sold in the Series A Private Placement on or before February 14, 2015 (the “Filing Date”).  The registration statement was declared effective on February 17, 2015.
	In connection with the Series A Private Placement, each of the holders of notes issued by the Company on June 3, 2014 (the “June 2014 Notes”) agreed to irrevocably waive their rights to anti-dilution protection under Section 5(b) of the June 2014 Notes in the event the Company issues additional securities at a per share price lower than the conversion price of the June 2014 Notes (the “June 2014 Note Waiver”). The obligations of the holder of the June 2014 Notes under the June 2014 Note Waiver will be binding on all assignees of the June 2014 Notes. Additionally, holders of the June 2014 Notes waived their rights of participation with respect to the June 2014 Private Placement and agreed to subordinate their participation rights to the Series A Purchaser’s Participation Right.
	In connection with the  Series A Private Placement, holders of approximately 86% of outstanding warrants issued by the Company in its public offering on July 30, 2013 and in connection with the conversion by certain holders of the Company’s outstanding debt in connection with the Company’s public offering (collectively, the “July 2013 Warrants”) agreed to irrevocably waive their rights to anti-dilution protection under Section 2(b) of the July 2013 Warrants in the event the Company issues additional securities at a per share price lower than the exercise price of the July 2013 Warrants (the “July 2013 Warrant Waiver”). The obligations of the holder of the July 2013 Warrants under the July 2013 Warrant Waiver will be binding on all assignees of the July 2013 Warrants.
	As a result of the foregoing, the Company’s cash balances would have increased to approximately $24,750,000, the stockholder’s equity (deficit) would have increased from $(14,398,011) to approximately $22,400,000 and the $13,541,138 in derivative liability on the Company’s balance sheet was reduced to approximately $1,390,880, if the January 2, 2015 transaction described herein had closed on December 31, 2014.
	Additionally it should be noted that the Company’s financial statements for the years ending December 31, 2013 were prepared on the basis the Company would continue as a going concern but there was substantial doubt regarding this assumption expressed by our auditors. As a result of this January 2, 2015 financing, this note regarding doubt about the Company’s ability to continue as a going concern for at least the next 12 months has been deleted.
	Recent Common Stock Issuances:
	Since January 1, 2015, the Company has issued a total of 295,000 shares of its restricted common stock as stock awards under the Company’s 2014 Stock Plan and 40,000 shares of its restricted common stock for investor relations services.
	Recent Warrant Exercises:
	Since January 1, 2015, the Company has received requests to exercise 4,665,892 warrants that were associated with its August 2013 stock offering which were exercisable into common stock at $2.25 per share. A total of 504,500 of these warrants have been exercised for cash, netting proceeds of $1,135,125 to the Company. The balance of 4,161,392 warrants was exercised on a cashless basis resulting in the issuance of 3,551,281 common shares. The Company did not offer the holders of warrants any inducement to exercise. There are currently 65,100 warrants outstanding from the August 2013 offering and the total warrants outstanding as of the date of the filing of this Annual Report are 537,102.
	Recent Note Conversions:
	Since January 1, 2015, $337,500 in convertible notes have been converted to 150,000 shares of common stock during this same time period in 2015. Total convertible notes outstanding as of the date of the filing of this Annual Report, excluding accrued interest is $2,037,500, which is convertible into 905,556 shares.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Operations	Operations
	Vuzix Corporation (the Company) was formed in 1997 under the laws of the State of Delaware and maintains its corporate offices in Rochester, New York. The Company is engaged in the design, manufacture, marketing and sale of devices that are worn like eyeglasses and which feature built-in video screens that enable the user to view video and digital content, such as movies, computer data, the Internet or video games. Our products (known commercially as “Video Eyewear”) are used to view high resolution video and digital information from portable devices, such as cell phones, portable media players, gaming systems and laptop computers and from personal computers. Our products provide the user with a virtual viewing experience that emulates viewing a large screen television or desktop computer monitor practically anywhere, anytime.
Principles of Consolidation	Principles of Consolidation
	The consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, Vuzix Europe. All significant inter-company transactions have been eliminated.
Segment Data, Geographic Information and Significant Customers	Segment Data, Geographic Information and Significant Customers
	The Company is not organized by market and is managed and operated as one business. A single management team that reports to the chief operating decision maker comprehensively manages the entire business. The Company does not operate any material separate lines of business or separate business entities. Accordingly, the Company does not accumulate discrete information, other than product revenue and material costs, with respect to separate product lines and does not have separately reportable segments as defined by FASB ASC Topic 280, “Disclosures about Segments of an Enterprise and Related Information,”
	Shipments to customers outside of the United States approximated 43% and 36% of sales in 2014 and 2013, respectively. No single international country represented more than 10% of revenues. The Company does not maintain significant amounts of long-lived assets outside of the United States other than tooling held by its third party manufacturers, primarily in China.
	The Company has at times had a concentration of sales to the U.S. government, they amounted to approximately 10% and 17% of sales in 2014 and 2013, respectively. Accounts receivable from the U.S. government accounted for 6% and 79% of accounts receivable at December 31, 2014 and 2013, respectively.
Foreign Currency Transactions	Foreign Currency Transactions
	The British Pound is the functional currency of the Company’s foreign subsidiary. Gains and losses arising upon settlement of foreign currency denominated transactions or balances are included in the determination of net loss.
Use of Estimates	Use of Estimates
	The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at year end and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
Concentration of Credit Risk	Concentration of Credit Risk
	The Company maintains its cash in bank deposit accounts, which at times may exceed federally insured limits.
Cash and Cash Equivalents	Cash and Cash Equivalents
	The Company’s cash received is applied against its revolving line of credit on a periodic basis based on projected monthly cash flows, reducing interest expense. Cash and cash equivalents can include highly liquid investments with original maturities of three months or less.
Fair Value of Financial Instruments	Fair Value of Financial Instruments
	The Company’s financial instruments primarily consists of cash and cash equivalents, accounts receivable, accounts payable, lines of credit, long-term debt and capital leases, customer deposits, accrued expenses, and income taxes payable.
	As of the consolidated balance sheet date, the estimated fair values of the financial instruments were not materially different from their carrying values as presented due to both the short maturities of these instruments and that the interest rates on borrowing approximate those that would have been available for loans for similar remaining maturity and risk profiles.
Accounts Receivable	Accounts Receivable
	The Company carries its trade accounts receivable at invoice amount less an allowance for doubtful accounts. The Company establishes an allowance for uncollectible trade accounts receivable based on the age of outstanding invoices and management’s evaluation of collectability of outstanding balances. These provisions are established when the aging of outstanding amounts exceeds allowable terms and are re-evaluated at each quarter end for adequacy. In determining the adequacy of the provision, the Company considers known uncollectible or at risk receivables. There was no allowance for doubtful accounts as of December 31, 2014 and 2013. The Company does not accrue interest on past due accounts receivable unless it goes into collection.
Inventories	Inventories
	Inventories are valued at the lower of cost or market using the weighted average first-in, first-out method. The Company includes direct overhead costs in its inventory valuation costing. The Company records provisions for excess, obsolete or slow moving inventory based on changes in customer demand, technology developments or other economic factors. The Company’s products have product life cycles that range on average from two to three years currently. At both the product introduction and product discontinuation stage, there is a higher degree of risk of inventory obsolescence. The provision for obsolete and excess inventory is evaluated for adequacy at each quarter end. The estimate of the provision for obsolete and excess inventory is partially based on expected future product sales, which are difficult to forecast for certain products.
Revenue Recognition	Revenue Recognition
	The Company recognizes revenue from product sales in accordance with FASB ASC Topic 605 “Revenue Recognition”. Product sales represent the majority of the Company’s revenue. The Company recognizes revenue from these product sales when persuasive evidence of an arrangement exists, delivery has occurred, the sale price is fixed or determinable, and collectability is reasonably assured. The Company sells its products on terms which transfer title and risk of loss at a specified location, typically shipping point. Accordingly, revenue recognition from product sales occurs when all factors are met. If these conditions are not met, the Company will defer revenue recognition until such time as these conditions have been satisfied. The Company collects and remits sales taxes in certain jurisdictions and reports revenue net of any associated sales taxes. The Company also sells certain products through distributors who are granted limited rights of return for stock balancing against purchases made within a prior 90 day period, including price adjustments downwards that the Company implements on any existing inventory. The provision for product returns and price adjustments is assessed for adequacy both at the time of sale and at each quarter end and is based on recent historical experience and known customer claims and was not material as of December 31, 2014 or 2013.
	Revenue from any engineering consulting and other services is recognized at the time the services are rendered. The Company accounts for its longer-term development contracts, which to date have all been firm fixed-priced contracts, on the percentage-of-completion method, whereby income is recognized as work on contracts progresses, but estimated losses on contracts in progress are charged to operations immediately. The percentage-of-completion is determined using the cost-to-cost method. Amounts are generally billed on a monthly basis. To date all such contracts have been less than one calendar year in duration.
	The Company recognizes software license revenue under ASC 985-605 “Software Revenue Recognition” and under ASC 605-25 “Revenue Arrangements with Multiple Deliverables”, and related interpretations, as amended.
	Licensed software may be sold as a stand-alone element, with other software elements, or in conjunction with hardware products. When the Company’s products consists of more than one element, it is considered to be a multiple element arrangement (MEA). When sold as a stand-alone element, the revenue is recognized upon shipment as discussed above. When sold as part of a MEA, revenue from the licensed software is recognized when the product and embedded software is shipped to the customer.
	For either a single element transaction or a MEA, the Company allocates consideration to all deliverables based on their relative stand-alone selling prices. Amendments to ASC 605-25, which became effective January 1, 2011, establish a hierarchy to determine the stand-alone selling price as follows:
		·	Vendor Specific Objective Evidence of the fair value (VSOE),
		·	Third Party Evidence (TPE)
		·	Best Estimate of the Selling Price (ESP)
	Sales which constitute a MEA are accounted for by determining if the elements can be accounted for as separate accounting units, and if so, by applying values to those units, per the hierarchy above. If VSOE is not available, management estimates the fair selling price using historical pricing for similar items, in conjunction with current pricing and discount policies.
	Revenue from licensed software is recognized upon shipment and in accordance with industry-specific software recognition accounting guidance. Software updates that will be provided free of charge are evaluated on a case-by-case basis to determine whether they meet the definition of an upgrade and create a multiple element arrangement. The consideration allocated to the unspecified software upgrade rights and non-software services is deferred and recognized rateably over the 24-month estimated life of the devices. The Company’s BESP for the unspecified software upgrade right and non-software services is $25 per unit for the M100 Smart Glass.
	Fees charged to customers for post-contract Technical Support are recognized ratably over the term of the contract. Costs related to maintenance obligations are expensed as incurred.
Unearned Revenue	Unearned Revenue
	These amounts represent deferred revenue against unfulfilled deliverables of multiple-element products, including unspecified post-delivery support and software updates.
Tooling and Equipment	Tooling and Equipment
	Tooling and equipment are stated at cost. Depreciation of tooling and equipment is provided for using the straight-line method over the following estimated useful lives:
	Computers and Software	3 years
	Manufacturing Equipment	5 years
	Tooling	3 years
	Furniture and Equipment	5 years
	Repairs and maintenance costs are expensed as incurred. Asset betterments are capitalized.
Patents and Trademarks	Patents and Trademarks
	The Company capitalizes the costs of obtaining its patents and registration of Trademarks. Such costs are accumulated and capitalized during the filing periods, which can take several years to complete. Successful applications that result in the granting of a patent or trademark are then amortized over 15 years on a straight-line basis. Unsuccessful applications are written off and expensed in the fiscal period where the application is abandoned or discontinued.
Software Development Costs	Software Development Costs
	The Company capitalizes the costs of obtaining its software once technological feasibility has been determined by management. Such costs are accumulated and capitalized and projects can take several years to complete. Unsuccessful or discontinued software projects are written off and expensed in the fiscal period where the application is abandoned or discontinued. Costs incurred internally in researching and developing a computer software product are charged to expense until technological feasibility has been established for the product. Once technological feasibility is established, all software costs are capitalized until the product is available for general release to customers. Judgment is required in determining when technological feasibility of a product is established. Once the product is available for general release, accumulated costs are amortized over the life of the asset. The amortization of these costs is included in cost of revenue over the estimated life of the products, which currently is estimated as 3 years using a straight-line basis.
Long-Lived Assets	Long-Lived Assets
	The Company regularly assesses all of its long-lived assets for impairment when events or circumstances indicate their carrying amounts may not be recoverable, in accordance with FASB ASC Topic 360-10, “Accounting for the Impairment or Disposal of Long-Lived Assets.” In 2014, an impairment charge of $104,716 was recorded related to abandoned patents and trademarks. In 2013, an impairment charge of $73,423 was recorded related to abandoned patents and trademarks.
Research and Development	Research and Development
	Research and development costs, are expensed as incurred consistent with the guidance of FASB ASC Topic 730, “Research and Development,” and include employee related costs, office expenses, third party design and engineering services, and new product prototyping costs. Costs incurred internally in researching and developing a computer software product are charged to expense until technological feasibility has been established for the product.
Shipping and Handling Costs	Shipping and Handling Costs
	Amounts charged to customers and costs incurred by the Company related to shipping and handling are included in net sales and cost of goods sold, respectively, in accordance with FASB ASC Topic 605-45, “Revenue Recognition – Principal Agent Consideration”, “Accounting for Shipping and Handling Fees and Costs.”
Provision for Future Warranty Costs	Provision for Future Warranty Costs
	The Company provides for the estimated returns under warranty and the costs of fulfilling our obligations under product warranties at the time the related revenue is recognized. The Company estimates the costs based on historical and projected product failure rates, historical and projected repair costs, and knowledge of specific product failures (if any). The specific warranty terms and conditions vary depending upon the country in which we do business, but generally include parts and labor over a period generally ranging from one to two years from the date of product shipment. The Company provides a reserve for expected future warranty returns at the time of product shipment or produces over-builds to cover replacements. We regularly reevaluate our estimates to assess the adequacy of the recorded warranty liabilities and adjust the amounts as necessary each quarter end and is based on historical experience of warranty claims and costs.
Customer Deposits	Customer Deposits
	Customer deposits represents money the Company received in advance of providing a product or engineering services to a customer. All such deposits are short term in nature as the Company delivers the product, unfulfilled portions or engineering services to the customer before the end of its next annual fiscal period. These deposits are credited to the customer against product deliveries or at the completion of the customer’s order.
Advertising	Advertising
	Advertising costs are expensed as incurred and recorded in “Selling and Marketing” in the Consolidated Statements of Operations. Advertising expense for the years ended December 31, 2014 and 2013 amounted to $192,181 and $231,552, respectively.
Income Taxes	Income Taxes
	The Company accounts for income taxes in accordance with FASB ASC Topic 740-10, “Income Taxes.” Accordingly, the Company provides deferred income tax assets and liabilities based on the estimated future tax effects of differences between the financial and tax bases of assets and liabilities based on currently enacted tax laws. A valuation allowance is established for deferred tax assets in amounts for which realization is not considered more likely than not to occur.
	The Company reports any interest and penalties accrued relating to uncertain income tax positions as a component of the income tax provision.
Earnings Per Share	Earnings Per Share
	Basic earnings per share is computed by dividing the net (loss) income less accrued dividends on any outstanding preferred stock by the weighted average number of common shares outstanding for the period. Diluted earnings per share calculations reflect the assumed exercise of all dilutive employee stock options and warrants applying the treasury stock method promulgated by FASB ASC Topic 260, “Earnings Per Share” and the conversion of any outstanding convertible preferred shares or notes payable that are-in-the-money, applying the as-if-converted method. However, if the assumed exercise of stock options and warrants and the conversion of any preferred shares or convertible notes payable are anti-dilutive, basic and diluted earnings per share are the same for all periods. As a results of the net loss generated in 2014 and 2013 all outstanding instruments would be antidilutive. As of December 31, 2014 and 2013, there were 7,012,767 and 7,362,293 respectively, of common stock share equivalents potentially issuable under convertible debt agreements, options, and warrants that could potentially dilute basic earnings per share in the future. See Note 22 for details of dilutive and potentially dilutive securities issued after December 31, 2014.
Stock-Based Employee Compensation	Stock-Based Employee Compensation
	The Company accounts for share-based compensation to employees and directors in accordance with FASB ASC Topic 718 “Compensation Stock Expense,” which requires that compensation expense be recognized in the consolidated financial statements for share-based awards based on the grant-date fair value using a Black-Scholes valuation model of those awards. The Company uses the fair market value of our common stock on the date of each option grant based on market price of the Company’s common shares. Stock-based compensation expense includes an estimate of forfeitures and is recognized over the requisite service periods of the awards on a straight-line or graded vesting basis, which is generally commensurate with the vesting term. Stock-based compensation expense associated with stock option grants for the years ending December 31, 2014 and 2013 was $260,747 and $159,272, respectively.
	The Company issues new shares upon stock option exercises. Please refer to Note 16 Stock Option Plans, for further information.
Derivative Liability and Fair Value Measurements	Derivative Liability and Fair Value Measurements
	FASB ASC Topic 820, “Fair Value Measurements and Disclosures” defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements. ASC 820 clarifies that fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. ASC 820 permits an entity to measure certain financial assets and financial liabilities at fair value with changes in fair value recognized in earnings each period. In accordance with ASC 815-10-25, we measured the derivative liability using a Lattice pricing model at their issuance date and subsequently they are remeasured. Accordingly, at the end of each quarterly reporting date the derivative fair market value is remeasured and adjusted to current market value. Derivatives that have more than one year remaining in their life are shown as long term derivative liabilities.
	Significant unobservable inputs are used in the fair value measurement of the Company’s derivative liability. The primary input factors driving the economic or fair value of the derivative liabilities related to the warrants and convertible notes are the stock price of the Company’s shares, the price volatility of the shares, reset events, and exercise behavior. An important valuation input factor used in determining fair value was the expected volatility of observed share prices and the probability of projected resets in warrant exercise and note conversion prices from financing events before each security’s maturity. For exercise behavior the Company assumed that without a target price of 2 times the projected reset price or higher that the holders of the warrants and convertible notes would hold to maturity. In determining the fair value of the derivatives it was assumed that the Company’s business would be conducted as a going concern and that holding to maturity was reasonable. Further the January 2, 2015 Series A Preferred financing reduced the expected probably to near zero for price resets from financing events.
	ASC 820 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value. Level 1 inputs are quoted prices in active markets for identical assets or liabilities. Level 2 inputs are inputs other than quoted prices included in Level 1 that are directly or indirectly observable for the asset or liability. Such inputs include quoted prices in active markets for similar assets and liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability, or inputs derived principally from or corroborated by observable market data by correlation or other means. Level 3 inputs are unobservable inputs for the asset or liability. Such inputs are used to measure fair value when observable inputs are not available.
Recent Accounting Pronouncements	Recent Accounting Pronouncements
	In May 2014, the Financial Accounting Standards Board issued Accounting Standards Update No. 2014-09 ("ASU 2014-09"), Revenue from Contracts with Customers, an updated standard on revenue recognition. ASU 2014-09 provides enhancements to the quality and consistency of how revenue is reported while also improving comparability in the financial statements of companies reporting using International Financial Reporting Standards and GAAP. The core principle of the new standard is for companies to recognize revenue to depict the transfer of goods or services to customers in amounts that reflect the consideration to which the company expects to be entitled in exchange for those goods or services. The new standard also will result in enhanced disclosures about revenue, provide guidance for transactions that were not previously addressed comprehensively, and improve guidance for multiple-element arrangements. ASU 2014-09 will be effective in the first quarter of fiscal 2017 and may be applied on a full retrospective or modified retrospective approach. The Company is still currently evaluating the impact of implementation of this standard on its financial statements.
	In August 2014, the FASB issued ASU 2014-15, ”Presentation of Financial Statements – Going Concern”, which provides guidance on determining when and how to disclose going-concern uncertainties in the financial statements. The new standard requires management to perform interim and annual assessments of an entity’s ability to continue as a going concern within one year of the date the financial statements are issued. An entity will be required to provide certain disclosures if conditions of events raise substantial doubt about the entity’s ability to continue as a going concern. The ASU applies to all entities and is effective for annual periods ending after December 15, 2016, and interim periods thereafter, with early adoption permitted. We are currently evaluating the impact of the adoption of ASU 2014-15 on our consolidated financial statements and have not yet determined when we will adopt the standard.
	There are no other recent accounting pronouncements that are expected to have a material impact on the consolidated financial statements.

Inventories_Net_Tables

Inventories, Net (Tables)	12 Months Ended
	Dec. 31, 2014
Inventory Disclosure [Abstract]
Schedule of Inventories	Inventories consisted of the following:
		December 31,		December 31,
		2014		2013
	Purchased Parts and Components	$	1,251,224	$	1,094,250
	Work in Process		25,974		153,065
	Finished Goods		300,889		280,279
	Less: Reserve for Obsolescence		-666,138		-573,967
	Net	$	911,949	$	953,627

Tooling_and_Equipment_Net_Tabl

Tooling and Equipment, Net (Tables)	12 Months Ended
	Dec. 31, 2014
Property, Plant and Equipment, Net [Abstract]
Property, Plant and Equipment	Tooling and equipment consisted of the following:
		December 31,		December 31,
		2014		2013
	Tooling and Manufacturing Equipment	$	1,374,751	$	1,748,006
	Computers and Software		581,472		645,429
	Furniture and Equipment		607,327		749,233
		$	2,563,550	$	3,142,668
	Less: Accumulated Depreciation		-2,146,585		-2,696,339
	Net	$	416,965	$	446,329

Patents_and_Trademarks_Net_Tab

Patents and Trademarks, Net (Tables)	12 Months Ended
	Dec. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Finite-Lived Intangible Assets		December 31,		December 31,
		2014		2013
	Patents and Trademarks	$	697,591	$	777,593
	Less: Accumulated Amortization		-274,102		-281,985
	Net	$	423,489	$	495,608

Software_Development_Costs_Net1

Software Development Costs, Net (Tables)	12 Months Ended
	Dec. 31, 2014
Research and Development [Abstract]
Schedule Of Software Development Costs		December 31,		December 31,
		2014		2013
	Software Development Costs	$	859,351	$	240,561
	Less: Accumulated Amortization		-71,613		—
	Net	$	787,738	$	240,561

Debt_Issuance_Costs_Tables

Debt Issuance Costs (Tables)	12 Months Ended
	Dec. 31, 2014
Debt Disclosure [Abstract]
Schedule Of Debt issuance Cost
		December 31,		December 31,
		2014		2013
	Debt Issuance Costs	$	139,340	$	—
	Less: Accumulated Amortization		-26,819		—
	Total	$	112,521	$	—

Notes_Payable_Tables

Notes Payable (Tables)	12 Months Ended
	Dec. 31, 2014
Notes Payable [Abstract]
Notes payable represent promissory notes payable	Notes payable represent promissory notes payable by the Company.
		December 31,		December 31,
		2014		2013
	Note payable to officers and shareholders of the Company. Principal along with accrued interest is payable on demand and paid on December 31, 2014. The notes bear interest at 18.5% and secured by all the assets of the Company.	$	37,038	$	229,787
	Note payable secured by all the assets of Company and the guarantee of its President and CEO. The effective interest rate was 31%. The note was repaid in full during the year ended December 31, 2014.		—		37,383
	Note payable to an officer of the Company due on December 31, 2014. The note was secured by all the assets of the Company. The note was repaid in full during the year ended December 31, 2014.		—		11,297
		$	37,038	$	278,467

Accrued_Expenses_Tables

Accrued Expenses (Tables)	12 Months Ended
	Dec. 31, 2014
Payables and Accruals [Abstract]
Components of Accrued Expenses	Accrued expenses consisted of the following:
		December 31,		December 31,
		2014		2013
	Accrued Wages and Related Costs	$	101,445	$	91,385
	Accrued Compensation		428,786		360,670
	Accrued Professional Services		45,000		69,500
	Accrued Warranty Obligations		39,624		31,619
	Accrued Interest		75,471		36,935
	Other Accrued Expenses		8,741		1,090
	Total	$	699,067	$	591,199
Changes in Accrued Warranty Obligations	The changes in the Company’s accrued warranty obligations for the years ended December 31, 2014 and 2013 were as follows:
	Accrued Warranty Obligations at December 31, 2012	$	93,788
	Reductions for Settling Warranties		-74,287
	Warranty Issued During Year		12,118
	Accrued Warranty Obligations at December 31, 2013		31,619
	Reductions for Settling Warranties		-96,460
	Warranty Issued During Year		104,465
	Accrued Warranty Obligations at December 31, 2014	$	39,624

Derivative_Liability_and_Fair_1

Derivative Liability and Fair Value Measurements (Tables)	12 Months Ended
	Dec. 31, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule Of Assets And Liabilities Measured At Fair Value On A Recurring Basis	Assets and liabilities measured at fair value on a recurring basis are as follows at December 31, 2014:
		Total			(Level 1)			(Level 2)		Level (3)
	Assets	$	—		$	—		$	—	$	—
	Total assets measured at fair value		—			—			—		—
	Liabilities
	Note Conversion Feature Liability in 2014		2,806,942			—			—		2,806,942
	Warrant Liability		10,734,196			—			—		10,734,196
	Total liabilities measured at fair value (Long-Term)	$	13,541,138		$	—		$	—	$	13,541,138
	Assets and liabilities measured at fair value on a recurring basis are as follows at December 31, 2013
		Total			(Level 1)			(Level 2)		Level (3)
	Assets	$	—		$	—		$	—	$	—
	Total assets measured at fair value		—			—			—		—
	Liabilities
	Warrant Liability		12,035,816			—			—		12,035,816
	Total liabilities measured at fair value (Long-Term)	$	12,035,816		$	—		$	—	$	12,035,816
Schedule of Fair Value Level 3 warrant liabilities	Fair value – December 31,2012	$	—
	Warrants issue during period		9,067,283
	Reclassification (reset expiration) of warrant liabilities to Additional Paid-in Capital		-526,245
	Reclassification of warrant exercises to Additional Paid-in Capital		-80,500
	Change in fair value for the period of warrant derivative liability		-3,575,278
	Fair value – December 31, 2013		12,035,816
	Reclassification of warrant exercises to Additional Paid-in Capital		-2,127,405
	Change in fair value for the period of warrant derivative liability		825,786
	Convertible debt issued with an embedded conversion price adjustment provision		1,938,988
	Extinguishment of liability upon conversion of debt		-500,261
	Change in fair value of debt conversion price adjustment for the period		1,368,215
	Fair value – December 31, 2014	$	13,541,138
Schedule Of Fair Value Of Warrants	The following summary table shows the assumptions used to compute the fair value of the embedded conversion option when granted at issuance and as of December 31, 2014:
		December 31, 2014				At Issuance – June 3,
						2014
	Assumptions for Pricing Model:
	Expected term in years		2.67				3
	Volatility range for years 1 to 5		81	%			57	%
	Expected annual dividends		None				None
	Value of convertible debt price adjustment:
	Fair value of debt embedded conversion price adjustment option	$	2,806,942			$	1,938,988
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques	The Monte Carlo Options Lattice pricing model was used to estimate the fair value of warrants outstanding:
		December 31,			December 31,			At Issuance
		2014			2013			Aug 5, 2013
	Assumptions for Pricing Model:
	Expected term in years		3.47 to 4.04			4.2 to 4.6			4.62 to 5.0
	Volatility range for years		72 to 81%			56 to 62%			61 to 110%
	Risk-free interest rate		0.93 to 1.83%			1.75%			0.77 to 1.41%
	Expected annual dividends		None			None			None
	Value of warrants outstanding:
	Fair value of warrants	$	10,734,196		$	12,035,816		$	9,067,283

LongTerm_Debt_Tables

Long-Term Debt (Tables)	12 Months Ended
	Dec. 31, 2014
Debt Disclosure [Abstract]
Components of Long-Term Debt	Long-term debt consisted of the following at December 31:
		December 31,		December  31,
		2014		2013
	Note payable for research and development equipment. The principal is subject to a fixed semi-annual repayment schedule commencing October 31, 2013 over 48 months. The note carries a 0% interest rate.		186,131		256,727
	The note carries a 0% interest, but imputed interest has been accrued based on a 12% discount rate and is reflected as a reduction in the principal.		-46,399		-71,701
	Note payable for which the principal and interest is subject to a fixed blended repayment schedule of 36 months, commencing July 15, 2013. The loan bears interest at 12% per annum and is secured by a subordinated position in all the assets of the Company.		50,874		84,790
	Convertible, Senior Secured Notes payable. The principal is due June 3, 2017 and no principal payments are required. The notes carry a 5% interest, payable upon the note’s maturity. Both the interest plus accrued interest is convertible into shares of the Company’s common shares at $2.25, subject to normal adjustments. The notes are secured by a first security position in all the assets of the Company. Most of the notes are held by existing stockholders of the Company.		2,375,000		—
	Unamortized debt discount related to derivative liability associated with above notes’ conversion price that is subject to adjustment in the event of subsequent equity sales at a lower purchase price (subject to certain exceptions). Upon issuance on June 3, 2014 the discount was $1,938,988. As of December 31, 2014 a net of $368,223 of the discount was recognized as interest expense and $222,580 was reversed due to conversions of the notes into shares of common stock. A net gain of $29,262 was recorded on the conversion of $625,000 in notes for the year ending December 31, 2014 resulting from the extinguishment of the debt and the related derivative liability.		-1,348,185		—
		$	1,217,421	$	269,816
	Less: Amount Due Within One Year		-128,425		-99,320
	Amount Due After One Year	$	1,088,996	$	170,496
Aggregate maturities for all long-term borrowings	The calendar year aggregate maturities for all long-term borrowings exclusive of discounts as of December 31, 2014 are as follows:
	Total Aggregate Maturity For Period	Amounts
	2015	$	153,727
	2016		83,278
	2017		2,375,000
	Total Required Principal Payments Exclusive of Debt Discounts		2,612,005
	Total Unamortized Debt Discounts		-1,394,584
	Total Net Long-Term Borrowings as of December 31, 2014	$	1,217,421

Capital_Lease_Obligations_Tabl

Capital Lease Obligations (Tables)	12 Months Ended
	Dec. 31, 2014
Capital Lease Obligations [Abstract]
Capital lease obligation payments	The related equipment is collateral to the leases. Final payments are due through September 2015.
		December 31,		December 31,
		2014		2013
	Total Principal Payments	$	16,882	$	41,552
	Less: Amount Due Within One Year		-16,882		-24,670
	Amount Due After One Year	$	—	$	16,882
Annual requirements for retirement of the capital lease obligations	Annual requirements for retirement of the capital lease obligations are as follows:
		Amount
	2015	$	18,445
	Total Minimum Lease Payments	$	18,445
	Less: Amount Representing Interest		-1,563
	Present Value of Minimum Lease Payments	$	16,882
Summary of assets held under capital leases	The following is a summary of assets held under capital leases:
	December 31,	2014		2013
	Computers and Software	$	16,200	$	30,692
	Furniture and Equipment		35,083		35,083
		$	51,283		65,775
	Less: Accumulated Depreciation		-42,230		-52,275
	Net	$	9,053	$	13,500

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Schedule Of Pre Tax Earnings	Pre-tax earnings consisted of the following for the years ended December 31, 2014 and 2013:
	December 31,	2014			2013
	Pre-Tax (Loss) Earnings
	U.S.	$	-7,868,858		$	-10,146,228
	Outside the U.S.		—			—
	Total Pre-Tax (Loss) Earnings	$	-7,868,858		$	-10,146,228
Schedule of Components of Income Tax Expense (Benefit)	The provision (benefit) for income taxes for the years ended December 31, 2014 and 2013 was as follows:
			2014			2013
	U.S. Income Taxes
	Current Provision	$	—		$	—
	Deferred Provision		—			—
	Income Taxes Outside the U.S.
	Current Provision		—			—
	Deferred Provision		—			—
	State Income Taxes
	Current Provision		—			—
	Deferred Provision		—			—
	Total Provision	$	—		$	—
Schedule of Effective Income Tax Rate Reconciliation	A reconciliation of the statutory U.S. federal income tax rate to the effective rates for the years ended December 31, 2014 and 2013 is as follows:
		2014				2013
	Federal Income Tax at Statutory Rate		34	%			34.4	%
	State Tax Provision, Net of Federal Benefit		0.2	%			0.5	%
	Foreign Income Taxed at Other Than 34%		0	%			-0.2	%
	Loss on Derivative Valuation		-11.1	%			-12.2	%
	Change in Rate Assumptions		0	%			41	%
	Other		-2.2	%			-0.3	%
	Effective Tax Rate		20.9	%			63.2	%
	Change in Valuations Allowance		-20.9	%			-63.2	%
	Net Effective Tax Rate		0	%			0	%
Schedule of Deferred Tax Assets and Liabilities	Deferred tax assets (liabilities) for the years ended December 31, 2014 and 2013 consist of the following:
		2014			2013
	Deferred Tax Assets
	Net Operating Loss Carry-forwards		11,418,496			9,739,496
	Tax Credit Carry-forwards		1,433,229			1,466,429
	Other		876,606			486,497
	Total Deferred Tax Assets	$	13,728,331		$	11,692,422
	Deferred Tax Liabilities
	Other		614,027			226,344
	Net Deferred Tax Assets Before Valuation Allowance	$	13,114,304		$	11,466,078
	Valuation Allowance		-13,114,304			-11,466,078
	Net Deferred Tax Assets	$	—		$	—

Stock_Warrants_Tables

Stock Warrants (Tables)	12 Months Ended
	Dec. 31, 2014
Stockholders' Equity Note [Abstract]
Changes in Warrants	The following table shows the various changes in warrants for the years December 31, 2014 and 2013.
		December 31,	December 31,
		2014	2013
	Warrants Outstanding, Beginning of Year	7,147,775	656,641
	Exercised During the Year	-1,285,746	-59,300
	Issued During the Year	—	6,551,654
	Forfeited During the Year	-625,369	-1,220
	Warrants Outstanding, End of Year	5,236,660	7,147,775

Stock_Option_Plans_Tables

Stock Option Plans (Tables)	12 Months Ended
	Dec. 31, 2014
Stock Option Plans [Abstract]
Stock option plans	Under the 2014 Plan, the Company may grant stock options, stock appreciation rights, performance awards of stock and/or cash, and stock awards of restricted stock.
		2007 Plan		2009 Plan		2014 Plan		Total
	Outstanding as of  December 31, 2014	57,209		120,842		542,500		720,551
	Available for future issuance under plan	—		—		457,500		457,500
	Totals authorized by plan	57,209		120,842		1,000,000		1,178,051
Summary of Stock Option Activity	The following table summarizes stock option activity for the years ended December 31, 2014 and 2013:
				Weighted			Weighted Average
		Number of		Average			Remaining Life
		Shares		Exercise Price			(years)
	Outstanding at December 31, 2012	192,729		$	10.68			4.52
	Granted	45,000			2
	Exercised	—			—
	Expired or Forfeited	-23,211			2.71
	Outstanding at December 31, 2013	214,518		$	9.72			6.11
	Granted	548,000			2.63
	Exercised	-10,819			1.71
	Expired or Forfeited	-31,148			2.71
	Outstanding at December 31, 2014	720,551		$	4.46			8.56
Summary of assumptions used to compute the fair value of stock options granted	The following summary table shows the assumptions used to compute the fair value of stock options granted during 2014 and 2013 and their estimated value:
	December 31,	2014				2013
	Assumptions for Black-Scholes:
	Expected term in years		5.6 to 10 .0				10
	Volatility		118.6 to 119.7%				128.8	%
	Risk-free interest rate		1.70 to 2.42%				2.81	%
	Expected annual dividends		None				None
	Value of options granted:
	Number of options granted		548,000				45,000
	Weighted average fair value/share	$	2.63			$	$2.00
	Fair value of options granted	$	1,241,904			$	81,884

Commitments_Tables

Commitments (Tables)	12 Months Ended
	Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
Contractual Payment Obligations for Operating Leases	Future minimum payments required under operating lease obligations as of December 31, 2014 were as follows:
				Total Minimum
		2015		Lease Payments
		$	81,080	$	81,080

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Property Plant And Equipment Useful Life) (Detail)	12 Months Ended
	Dec. 31, 2014
Computers and Software
Property, Plant and Equipment, Estimated Useful Lives	3 years
Manufacturing Equipment
Property, Plant and Equipment, Estimated Useful Lives	5 years
Tooling
Property, Plant and Equipment, Estimated Useful Lives	3 years
Furniture and Equipment
Property, Plant and Equipment, Estimated Useful Lives	5 years

Summary_of_Significant_Account3

Summary of Significant Accounting Policies (Additional Information) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Summary Of Significant Accounting Policies [Line Items]
Percentage Of Revenues From External Customers	43.00%	36.00%
Maximum Percentage Of Revenues From Foreign Countries	10.00%
Percentage On Accounts Receivable	6.00%	79.00%
Advertising Expense	$192,181	$231,552
Stock Options	260,747	159,272
Asset Impairment Charges	$104,716	$73,423
Finite-Lived Intangible Assets, Remaining Amortization Period	3 years
Earnings Per Share, Potentially Dilutive Securities	7,012,767	7,362,293
M100 Smart Glass
Summary Of Significant Accounting Policies [Line Items]
Best Selling Price Per Unit	25
Minimum
Summary Of Significant Accounting Policies [Line Items]
Finite-Lived Intangible Assets, Remaining Amortization Period	3 years
Trademarks and Patents
Summary Of Significant Accounting Policies [Line Items]
Finite-Lived Intangible Assets, Remaining Amortization Period	15 years
Minority Stockholder
Summary Of Significant Accounting Policies [Line Items]
Concentration Risk, Percentage	10.00%	17.00%

Inventories_Net_Components_of_

Inventories, Net (Components of Inventories) (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Inventory Disclosure [Line Items]
Purchased Parts and Components	$1,251,224	$1,094,250
Work in Process	25,974	153,065
Finished Goods	300,889	280,279
Less: Reserve for Obsolescence	-666,138	-573,967
Net	$911,949	$953,627

Tooling_and_Equipment_Net_Sche

Tooling and Equipment, Net (Schedule Of Tooling And Equipment) (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$2,563,550	$3,142,668
Less: Accumulated Depreciation	-2,146,585	-2,696,339
Net	416,965	446,329
Tooling and Manufacturing Equipment
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	1,374,751	1,748,006
Computers and Software
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	581,472	645,429
Funiture and Equipment
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$607,327	$749,233

Tooling_and_Equipment_Net_Addi

Tooling and Equipment, Net (Additional Information (Detail) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Property, Plant and Equipment [Line Items]
Depreciation and Amortization	$279,317	$377,840
Tooling and Equipment
Property, Plant and Equipment [Line Items]
Depreciation and Amortization	$225,267	$322,861

Patents_and_Trademarks_Net_Sch

Patents and Trademarks, Net (Schedule Of Patents and Trademarks) (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Finite-Lived Intangible Assets [Line Items]
Patents and Trademarks	$697,591	$777,593
Less: Accumulated Amortization	-274,102	-281,985
Net	$423,489	$495,608

Patents_and_Trademarks_Net_Add

Patents and Trademarks, Net (Additional Information) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Finite-Lived Intangible Assets [Line Items]
Amortization	$54,050	$54,979
Impairment of Patents and Trademarks	104,716	73,423
Amortization of Intangible Assets	71,613	0
Abandoned Patents and Trademarks
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months	50,000
Finite-Lived Intangible Assets, Amortization Expense, Year Two	50,000
Finite-Lived Intangible Assets, Amortization Expense, Year Four	50,000
Finite-Lived Intangible Assets, Amortization Expense, Year Three	50,000
Finite-Lived Intangible Assets, Amortization Expense, Year Five	50,000
Impairment of Patents and Trademarks	104,716	73,423
Amortization of Intangible Assets	166,500	98,788
Asset Impairment Cost	$61,784	$25,375

Software_Development_Costs_Net2

Software Development Costs, Net (Schedule Of Software Development Costs) (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Software Development Costs	$859,351	$240,561
Less: Accumulated Amortization	-71,613	0
Net	$787,738	$240,561

Software_Development_Costs_Net3

Software Development Costs, Net (Additional Information) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Amortization	$54,050	$54,979
Finite-Lived Intangible Assets, Remaining Amortization Period	3 years
Software and Software Development Costs [Member]
Amortization	71,613	0
Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months	286,000
Finite-Lived Intangible Assets, Amortization Expense, Year Two	$215,000
Minimum [Member]
Finite-Lived Intangible Assets, Remaining Amortization Period	3 years

Debt_Issuance_Costs_Detail

Debt Issuance Costs (Detail) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Debt Issuance Costs	$139,340	$0
Less: Accumulated Amortization	-26,819	0
Total	$112,521	$0

Debt_Issuance_Costs_Additional

Debt Issuance Costs (Additional Information)(Details) (Convertible Notes Payable [Member], USD $)	Dec. 31, 2014
Convertible Notes Payable [Member]
Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months	$46,000
Finite-Lived Intangible Assets, Amortization Expense, Year Two	$21,000

Line_of_Credit_Additional_Info

Line of Credit (Additional Information) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Line of Credit Facility [Line Items]
Line of credit	$112,500	$0
Line Of Credit, Current	$112,500	$0
Line of Credit Facility, Interest Rate Description	bank’s prime rate plus 1%

Notes_Payable_Notes_Payable_Re

Notes Payable (Notes Payable Represent Promissory Notes) (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Notes and Promissory Notes [Line Items]
Notes Payable (Note 11)	$37,038	$278,467
Officer and Shareholder
Notes and Promissory Notes [Line Items]
Notes Payable (Note 11)	37,038	229,787
President and Ceo | Secured By Asset [Member]
Notes and Promissory Notes [Line Items]
Notes Payable (Note 11)	0	37,383
Officer
Notes and Promissory Notes [Line Items]
Notes Payable (Note 11)	$0	$11,297

Notes_Payable_Notes_Payable_Re1

Notes Payable (Notes Payable Represent Promissory Notes) (Parenthetical) (Detail)	Jul. 15, 2013	Mar. 21, 2013	Dec. 31, 2014
Notes and Promissory Notes [Line Items]
Interest percentage	16.00%	16.00%
Officer and Shareholder
Notes and Promissory Notes [Line Items]
Interest percentage			18.50%
President and Ceo | Secured By Asset
Notes and Promissory Notes [Line Items]
Interest percentage			31.00%

Notes_Payable_Additional_Infor

Notes Payable (Additional Information) (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Notes and Promissory Notes [Line Items]
Accrued interest	$32,209	$61,130

Accrued_Expenses_Components_of

Accrued Expenses (Components of Accrued Expenses) (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Accrued Liabilities [Line Items]
Accrued Wages and Related Costs	$101,445	$91,385
Accrued Compensation	428,786	360,670
Accrued Professional Services	45,000	69,500
Accrued Warranty Obligations	39,624	31,619
Accrued Interest	75,471	36,935
Other Accrued Expenses	8,741	1,090
Total	$699,067	$591,199

Accrued_Expenses_Changes_in_Ac

Accrued Expenses (Changes in Accrued Warranty Obligations) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Class Of Warrant Or Right [Line Items]
Accrued Warranty Obligations , begining balance	$31,619	$93,788
Reductions for Settling Warranties	-96,460	-74,287
Warranty Issued During Year	104,465	12,118
Accrued Warranty Obligations , Ending balance	$39,624	$31,619

Accrued_Expenses_Additional_In

Accrued Expenses - Additional Information (Detail) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Officers Compensation Payable Compounding Monthly Interest Rate	8.00%
Employee-related Liabilities, Current	$393,536	$360,670
Interest Payable	$62,081	$28,173

Derivative_Liability_and_Fair_2

Derivative Liability and Fair Value Measurements (Schedule of Assets And Liabilities Measured At Fair Value On A Recurring Basis) (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets	$0	$0
Total assets measured at fair value	0	0
Note Conversion Feature Liability in 2014	2,806,942
Warrant Liability	10,734,196	12,035,816
Total liabilities measured at fair value (Long-Term)	13,541,138	12,035,816
Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets	0	0
Total assets measured at fair value	0	0
Note Conversion Feature Liability in 2014	0
Warrant Liability	0	0
Total liabilities measured at fair value (Long-Term)	0	0
Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets	0	0
Total assets measured at fair value	0	0
Note Conversion Feature Liability in 2014	0
Warrant Liability	0	0
Total liabilities measured at fair value (Long-Term)	0	0
Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets	0	0
Total assets measured at fair value	0	0
Note Conversion Feature Liability in 2014	2,806,942
Warrant Liability	10,734,196	12,035,816
Total liabilities measured at fair value (Long-Term)	$13,541,138	$12,035,816

Derivative_Liability_and_Fair_3

Derivative Liability and Fair Value Measurements (Schedule of Fair Value Level 3 Warrant Liabilities) (Detail) (USD $)	0 Months Ended	12 Months Ended
	Jun. 03, 2014	Dec. 31, 2014	Dec. 31, 2013
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Convertible debt issued with an embedded conversion price adjustment provision	$1,938,988	$2,806,942
Extinguishment of liability upon conversion of debt		-500,261
Warrant Liabilities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value -beginning of period		12,035,816	0
Warrants issue during period			9,067,283
Reclassification (reset expiration) of warrant liabilities to Additional Paid-in Capital			-526,245
Reclassification of warrant exercises to Additional Paid-in Capital		-2,127,405	-80,500
Change in fair value for the period of warrant derivative liability		825,786	-3,575,278
Convertible debt issued with an embedded conversion price adjustment provision		1,938,988
Extinguishment of liability upon conversion of debt		-500,261
Change in fair value of debt conversion price adjustment for the period		1,368,215
Fair value - end of period		$13,541,138	$12,035,816

Derivative_Liability_and_Fair_4

Derivative Liability and Fair Value Measurements (Compute The Fair Value Of Warrants Issued) (Detail) (USD $)	0 Months Ended	12 Months Ended
	Jun. 03, 2014	Dec. 31, 2014
Value of convertible debt price adjustment:
Fair value of debt embedded conversion price adjustment option	$1,938,988	$2,806,942
Embedded Conversion Option [Member]
Assumptions for Pricing Model:
Expected term in years	3 years	2 years 8 months 1 day
Volatility range for years 1 to 5	57.00%	81.00%

Derivative_Liability_and_Fair_5

Derivative Liability and Fair Value Measurements (Estimate the fair value of warrants outstanding) (Detail) (USD $)	0 Months Ended	12 Months Ended
	Aug. 05, 2013	Dec. 31, 2014	Dec. 31, 2013
Value of warrants outstanding:
Fair value of warrants	9,067,283	10,734,196	12,035,816
Warrant [Member]
Assumptions for Pricing Model:
Risk-free interest rate			1.75%
Warrant [Member] | Minimum [Member]
Assumptions for Pricing Model:
Expected term in years	4 years 7 months 13 days	3 years 5 months 19 days	4 years 2 months 12 days
Volatility range for years	61.00%	72.00%	56.00%
Risk-free interest rate	0.77%	0.93%
Warrant [Member] | Maximum [Member]
Assumptions for Pricing Model:
Expected term in years	5 years	4 years 14 days	4 years 7 months 6 days
Volatility range for years	110.00%	81.00%	62.00%
Risk-free interest rate	1.41%	1.83%

Derivative_Liability_and_Fair_6

Derivative Liability and Fair Value Measurements (Additional Information) (Detail) (USD $)	0 Months Ended	12 Months Ended
	Jun. 03, 2014	Dec. 31, 2014	Dec. 31, 2013
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right		4,730,992	6,008,516
Convertible Debt		$3,000,000
Fair Value Of Debt Embedded Conversion Price Adjustment Option	$1,938,988	$2,806,942

LongTerm_Debt_Components_of_Lo

Long-Term Debt (Components of Long-Term Debt) (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Debt Instrument [Line Items]
Long term debt	$1,217,421	$269,816
Less: Amount Due Within One Year	128,425	99,320
Amount Due After One Year	1,088,996	170,496
The note carries a 0% interest, but imputed interest has been accrued based on a 12% discount rate and is reflected as a reduction in the principal [Member]
Debt Instrument [Line Items]
Long term debt	-46,399	-71,701
Convertible to shares of the Company's common shares at 2.25, subject to adjustment
Debt Instrument [Line Items]
Long term debt	2,375,000	0
Unamortized debt discount related to derivative liability associated with above notesb conversion price that is subject to adjustment in the event of subsequent equity sales at a lower purchase price (subject to certain exceptions). Upon issuance on June 3, 2014 the discount was $1,938,988. As of December 31, 2014 a net of $368,223 of the discount was recognized as interest expense and $222,580 was reversed due to conversions of the notes into shares of common stock [Member]
Debt Instrument [Line Items]
Unamortized Debt Discount Related To Derivative Liability	-1,348,185	0
Notes Payable [Member] | The principal is subject to a fixed semi-annual repayment schedule commencing October 31, 2012 over 48 months [Member]
Debt Instrument [Line Items]
Long term debt	186,131	256,727
Notes Payable [Member] | The principal and interest is subject to a fixed blended repayment schedule of 36 months, commencing July 15, 2013 [Member]
Debt Instrument [Line Items]
Long term debt	$50,874	$84,790

LongTerm_Debt_Components_of_Lo1

Long-Term Debt (Components of Long-Term Debt) (Parenthetical) (Detail) (USD $)	0 Months Ended	12 Months Ended
	Jun. 03, 2014	Dec. 31, 2014	Dec. 31, 2013	Jul. 15, 2013	Mar. 21, 2013	Dec. 31, 2012
Debt Instrument [Line Items]
Long term debt, fixed interest repayment term		36 months
Long term debt, fixed interest rate				16.00%	16.00%
Fair Value Of Debt Embedded Conversion Price Adjustment Option	$1,938,988	$2,806,942
Unamortized debt discount related to derivative liability associated with notes [Member]
Debt Instrument [Line Items]
Interest Expense, Debt		368,223
Conversion of Stock, Amount Converted		$222,580
Notes Payable [Member] | Minimum [Member]
Debt Instrument [Line Items]
Long term debt, fixed interest repayment term		24 months
Notes Payable [Member] | The principal is subject to a fixed semi-annual repayment schedule commencing October 31, 2012 over 48 months [Member]
Debt Instrument [Line Items]
Long term debt, fixed interest repayment term		48 months	48 months
Long term debt repayment starting date		31-Oct-13	31-Oct-13
Long term debt, fixed interest rate		12.00%	0.00%
Notes Payable [Member] | The principal and interest is subject to a fixed blended repayment schedule of 36 months, commencing July 15, 2013 [Member]
Debt Instrument [Line Items]
Long term debt, fixed interest repayment term		36 months	36 months
Long term debt repayment starting date		15-Jul-13	15-Jul-13
Long term debt, fixed interest rate		12.00%	0.00%
Convertible, Senior Secured Term Debt [Member]
Debt Instrument [Line Items]
Long term debt, fixed interest repayment term		15 months
Long term debt, fixed interest rate						13.50%
Convertible Senior Secured Notes payable [Member]
Debt Instrument [Line Items]
Long term debt, fixed interest repayment term		3-Jun-17
Long term debt, fixed interest rate		5.00%
Debt Instrument, Convertible, Conversion Price		$2.25

LongTerm_Debt_Aggregate_Maturi

Long-Term Debt (Aggregate Maturities For All Long Term Borrowings) (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Jun. 30, 2012
Debt Instrument [Line Items]
2015	$153,727
2016	83,278
2017	2,375,000
Total Required Principal Payments Exclusive of Debt Discounts	2,612,005
Total Unamortized Debt Discounts	-1,394,584		-636,678
Total Net Long-Term Borrowings as of December 31, 2014	$1,217,421	$269,816

LongTerm_Debt_Additional_Infor

Long-Term Debt (Additional Information) (Detail) (USD $)	0 Months Ended		12 Months Ended		1 Months Ended	3 Months Ended
	Aug. 05, 2013	Jul. 15, 2013	Dec. 31, 2014	Dec. 31, 2013	Mar. 21, 2013	Dec. 31, 2014	Jun. 30, 2012	Mar. 27, 2013	Dec. 31, 2012
Line of Credit Facility [Line Items]
Repayment of Convertible, Senior Secured Term Debt Loan			$345,942	$2,137,983
Senior Secured debt			1,217,421	269,816		1,217,421
Senior Secured debt repayment term			36 months
Convertible, Senior Secured interest rate		16.00%			16.00%
Unamortized discount			1,394,584			1,394,584	636,678
Debt Conversion, Converted Instrument, Amount			625,000	2,882,333
Debt Conversion, Converted Instrument, Warrants or Options Issued		38,168
Investment Warrants Exercise Price			$2.28
Debt Issuance Cost			139,340	0
Investment Warrants Expiration term	5 years
Extinguishment of Debt, Gain (Loss), Net of Tax			29,262	-1,272,296
Unamortized Debt Issuance Expense			112,521	0		112,521
Proceeds from Issuance of Senior Long-term Debt			3,000,000	1,000,000
Debt Instrument, Interest Rate, Stated Percentage		16.00%			16.00%
Class of Warrant or Right, Exercise Price of Warrants or Rights	$2.25
Securities Purchase Agreement [Member]
Line of Credit Facility [Line Items]
Unamortized discount			685,965			685,965
Extinguishment of Debt, Gain (Loss), Net of Tax			1,272,296
Unamortized Debt Issuance Expense			240,637			240,637
IPO [Member]
Line of Credit Facility [Line Items]
Debt Conversion, Converted Instrument, Amount			1,755,570
Convertible Debt [Member]
Line of Credit Facility [Line Items]
Senior Secured debt								2,374,682
Maximum
Line of Credit Facility [Line Items]
Common Stock Warrants Issued			533,333
Exercise price of warrants			$7.47
Fair value of warrants			1,010,379			1,010,379
Convertible, Senior Secured Term Debt [Member]
Line of Credit Facility [Line Items]
Repayment of Convertible, Senior Secured Term Debt Loan			4,450,000
Senior Secured debt									619,122
Senior Secured debt repayment term			15 months
Convertible, Senior Secured interest rate									13.50%
Secured Long-term Debt, Noncurrent		200,000			800,000
Debt Instrument Repayment Penalty		40,000			160,000
Debt Instrument, Interest Rate, Stated Percentage									13.50%
Notes Payable | Minimum
Line of Credit Facility [Line Items]
Senior Secured debt repayment term			24 months
Senior Secured Convertible Note [Member]
Line of Credit Facility [Line Items]
Convertible, Senior Secured interest rate			5.00%			5.00%
Debt Instrument, Convertible, Conversion Price			$2.25			$2.25
Proceeds from Issuance of Senior Long-term Debt			3,000,000			625,000
Debt Instrument, Interest Rate, Stated Percentage			5.00%			5.00%
Conversion of Stock, Shares Converted						277,777
Senior Secured Convertible Note [Member] | Convertible Debt [Member]
Line of Credit Facility [Line Items]
Exercise price of warrants	$2.25
Two Debentures [Member]
Line of Credit Facility [Line Items]
Debt Issuance Cost			257,691
Hillair [Member] | February 1,2014 Securities Purchase Agreement
Line of Credit Facility [Line Items]
Debt Instrument, Periodic Payment		50,000			200,000
Hillair [Member] | August 1,2015 Securities Purchase Agreement [Member]
Line of Credit Facility [Line Items]
Debt Instrument, Periodic Payment		12,500			50,000
Hillair [Member] | May 1,2014 Securities Purchase Agreement
Line of Credit Facility [Line Items]
Debt Instrument, Periodic Payment		50,000			200,000
Hillair [Member] | August 1,2014 Securities Purchase Agreement [Member]
Line of Credit Facility [Line Items]
Debt Instrument, Periodic Payment		50,000			200,000
Hillair [Member] | August 1,2017 Securities Purchase Agreement [Member]
Line of Credit Facility [Line Items]
Debt Instrument, Periodic Payment		12,500			50,000
Hillair [Member] | August 1,2016 Securities Purchase Agreement [Member]
Line of Credit Facility [Line Items]
Debt Instrument, Periodic Payment		12,500			50,000
Hillair [Member] | March 21, 2018 Securities Purchase Agreement [Member]
Line of Credit Facility [Line Items]
Debt Instrument, Periodic Payment		12,500			50,000
Hillair [Member] | Securities Purchase Agreement [Member]
Line of Credit Facility [Line Items]
Exercise price of warrants	$2.25
Secured Long-term Debt, Noncurrent		200,000			800,000
Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate		16.00%			16.00%
Debt Instrument, Convertible, Conversion Price		5.24			$4.29
Debt Conversion, Converted Instrument, Warrants or Options Issued					186,480
Debt Instrument Repayment Penalty	40,000				160,000
Investment Warrants Expiration term		5 years			5 years
Class of Warrant or Right, Exercise Price of Warrants or Rights			$2.25		$4.72	$2.25
Gentry [Member]
Line of Credit Facility [Line Items]
Financial Advisor Fees			50,000
Conversion of Stock, Shares Issued			20,000
Investment Warrants Exercise Price			$4.72
Investment Owned, at Fair Value			$66,603			$66,603

Capital_Lease_Obligations_Equi

Capital Lease Obligations (Equipment Held Under Capital Lease Obligations Due) (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Capital Leased Assets [Line Items]
Total Principal Payments	$16,882	$41,552
Less: Amount Due Within One Year	16,882	24,670
Amount Due After One Year	$0	$16,882

Capital_Lease_Obligations_Annu

Capital Lease Obligations (Annual Requirements For Retirement Of The Capital Lease Obligations) (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Capital Leases Future Minimum Payments [Line Items]
2015	$18,445
Total Minimum Lease Payments	18,445
Less: Amount Representing Interest	-1,563
Present Value of Minimum Lease Payments	$16,882	$41,552

Capital_Lease_Obligations_Summ

Capital Lease Obligations (Summary Of Assets Held Under Capital Leases) (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Property, Plant and Equipment [Line Items]
Capital Leased Assets, Gross	$51,283	$65,775
Less: Accumulated Depreciation	-42,230	-52,275
Net	9,053	13,500
Funiture and Equipment
Property, Plant and Equipment [Line Items]
Capital Leased Assets, Gross	35,083	35,083
Computer and Software
Property, Plant and Equipment [Line Items]
Capital Leased Assets, Gross	$16,200	$30,692

Capital_Lease_Obligations_Addi

Capital Lease Obligations (Additional Information) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Capital Lease Obligations Additional Information [Line Items]
Capital Lease Obligation Monthly Lease Payments	$2,049
Capital Lease Obligation Interest Rate	26.71%
Depreciation	279,317	377,840
Assets Held under Capital Leases [Member]
Capital Lease Obligations Additional Information [Line Items]
Depreciation	$12,417	$17,247

Income_Taxes_PreTax_Earnings_D

Income Taxes (Pre-Tax Earnings) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Pre-Tax (Loss) Earnings
Total Pre-Tax (Loss) Earnings	($7,868,858)	($10,146,228)
UNITED STATES
Pre-Tax (Loss) Earnings
Total Pre-Tax (Loss) Earnings	-7,868,858	-10,146,228
Outside the U.S. [Member]
Pre-Tax (Loss) Earnings
Total Pre-Tax (Loss) Earnings	$0	$0

Income_Taxes_Provision_Benefit

Income Taxes (Provision Benefit For Income Taxes) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
U.S. Income Taxes
Current Provision	$0	$0
Deferred Provision	0	0
Income Taxes Outside the U.S.
Current Provision	0	0
Deferred Provision	0	0
State Income Taxes
Current Provision	0	0
Deferred Provision	0	0
Total Provision	$0	$0

Income_Taxes_Reconciliation_Of

Income Taxes (Reconciliation Of Effective Rate) (Detail)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Effective Income Tax Rate Reconciliation [Line Items]
Federal Income Tax at Statutory Rate	34.00%	34.40%
State Tax Provision, Net of Federal Benefit	0.20%	0.50%
Foreign Income Taxed at Other Than 34%	0.00%	-0.20%
Loss on Derivative Valuation	-11.10%	-12.20%
Change in Rate Assumptions	0.00%	41.00%
Other	-2.20%	-0.30%
Effective Tax Rate	20.90%	63.20%
Change in Valuations Allowance	-20.90%	-63.20%
Net Effective Tax Rate	0.00%	0.00%

Income_Taxes_Components_Of_Def

Income Taxes (Components Of Deferred Tax assets And liabilities) (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Deferred Tax Assets
Net Operating Loss Carry-forwards	$11,418,496	$9,739,496
Tax Credit Carry-forwards	1,433,229	1,466,429
Other	876,606	486,497
Total Deferred Tax Assets	13,728,331	11,692,422
Deferred Tax Liabilities
Other	614,027	226,344
Net Deferred Tax Assets Before Valuation Allowance	13,114,304	11,466,078
Valuation Allowance	-13,114,304	-11,466,078
Net Deferred Tax Assets	$0	$0

Income_Taxes_Additional_Inform

Income Taxes (Additional Information) (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Income Taxes Additional Information [Line Items]
Federal and State Net Operating Loss Carryforwards	$33,300,000
Percentage Of Valuation Allowance On Deferred Tax Assets	100.00%
Deferred Tax Assets, Tax Credit Carryforwards	$1,433,229	$1,466,429

Capital_Stock_Additional_Infor

Capital Stock (Additional Information) (Detail) (USD $)	0 Months Ended	12 Months Ended
	Aug. 05, 2013	Dec. 31, 2014	Dec. 31, 2013	Aug. 05, 2014
Capital Stock [Line Items]
Preferred Stock Shares Authorized		5,000,000	5,000,000
Preferred Stock Shares Issued		0	0
Preferred Stock Shares Outstanding		0	0
Stockholders' Equity, Reverse Stock Split		All per share amounts, outstanding shares, warrants, options and shares issuable pursuant to convertible securities for all periods reflect the Company’s 1-for-75 reverse stock split, which was effective February 6, 2013.
Common Stock Shares Issued	4,025,000	11,295,387	9,600,453
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	4,025,000
Common Stock Price Per Share	$2			$2
Class Of Warrant Or Right Share Price Of Warrants Or Rights	0.0001
Class of Warrant or Right, Exercise Price of Warrants or Rights	$2.25
Investment Warrants Expiration term	5 years
Proceeds From Issuance Public Offering	$8,050,000
Other Accrued Liabilities Current		8,741	1,090
Repayments of Debt	2,137,984
Payments of Debt Extinguishment Costs	200,000
Proceeds from Issuance Initial Public Offering	4,350,000
Debt Conversion, Converted Instrument, Amount		625,000	2,882,333
Other Offering Expenses [Member]
Capital Stock [Line Items]
Other Accrued Liabilities Current	1,358,641
Common Stock And Warrants [Member]
Capital Stock [Line Items]
Debt Conversion, Converted Instrument, Amount	2,316,007
Debt Instrument, Convertible, Conversion Price	$2
Common Stock And Warrants [Member] | Officer [Member]
Capital Stock [Line Items]
Debt Conversion, Converted Instrument, Amount	$1,642,569
Debt Instrument, Convertible, Conversion Price	$2

Stock_Warrants_Changes_in_Warr

Stock Warrants (Changes in Warrants) (Detail)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Class Of Warrant Or Right [Line Items]
Warrants Outstanding, Beginning of Year	7,147,775	656,641
Exercised During the Year	-1,285,746	-59,300
Issued During the Year	0	6,551,654
Forfeited During the Year	-625,369	-1,220
Warrants Outstanding, End of Year	5,236,660	7,147,775

Stock_Warrants_Additional_Info

Stock Warrants (Additional Information) (Detail) (USD $)	12 Months Ended	0 Months Ended
	Dec. 31, 2014	Aug. 05, 2013	Dec. 31, 2013	Dec. 31, 2012
Class of Warrant or Right [Line Items]
Weighted average term of warrants	3 years 7 months 6 days
Weighted average exercise price of warrants per share	$2.28
Class Of Warrant Or Right Outstanding	5,236,660		7,147,775	656,641
Warrants 1
Class of Warrant or Right [Line Items]
Class Of Warrant Or Right Outstanding		206,420
Warrants 2
Class of Warrant or Right [Line Items]
Class Of Warrant Or Right Outstanding		38,168
Minimum
Class of Warrant or Right [Line Items]
Outstanding Warrants Expiration Date	21-May-15
Minimum | Warrants 1
Class of Warrant or Right [Line Items]
Weighted average exercise price of warrants per share		$2.25
Minimum | Warrants 2
Class of Warrant or Right [Line Items]
Weighted average exercise price of warrants per share		$2.25
Maximum
Class of Warrant or Right [Line Items]
Outstanding Warrants Expiration Date	5-Aug-18
Maximum | Warrants 1
Class of Warrant or Right [Line Items]
Weighted average exercise price of warrants per share		$4.72
Maximum | Warrants 2
Class of Warrant or Right [Line Items]
Weighted average exercise price of warrants per share		$5.24

Stock_Option_Plans_Summary_Of_

Stock Option Plans (Summary Of Stock Option Plans) (Detail)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Stock Option Plan [Line Items]
Outstanding as of December 31, 2014	720,551	214,518	192,729
Available for future issuance under plan	457,500
Totals authorized by plan	1,178,051
2007 Plan
Stock Option Plan [Line Items]
Outstanding as of December 31, 2014	57,209
Available for future issuance under plan	0
Totals authorized by plan	57,209
2009 Plan
Stock Option Plan [Line Items]
Outstanding as of December 31, 2014	120,842
Available for future issuance under plan	0
Totals authorized by plan	120,842
2014 Plan
Stock Option Plan [Line Items]
Outstanding as of December 31, 2014	542,500
Available for future issuance under plan	457,500
Totals authorized by plan	1,000,000

Recovered_Sheet1

Stock Option Plans (Summary of Stock Option Activity) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Number of shares outstanding
Outstanding, Beginning Balance	214,518	192,729
Granted	548,000	45,000
Exercised	-10,819	0
Expired or Forfeited	-31,148	-23,211
Outstanding, Ending Balance	720,551	214,518	192,729
Weighted Average Exercise Price
Outstanding, Beginning Balance	$9.72	$10.68
Granted	$2.63	$2
Exercised	$1.71	$0
Expired or Forfeited	$2.71	$2.71
Outstanding, Ending Balance	$4.46	$9.72	$10.68
Weighted Average Remaining Life (Years)
Options Outstanding, Weighted Average Remaining Life (Years)	8 years 6 months 22 days	6 years 1 month 10 days	4 years 6 months 7 days

Stock_Option_Plans_Assumptions

Stock Option Plans (Assumptions Used To Compute The Fair Value Of Stock Options) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Assumptions for Pricing Model:
Expected term in years		10 years
Volatility		128.80%
Risk-free interest rate		2.81%
Value of options granted:
Number of options granted	548,000	45,000
Weighted average fair value/share	$2.63	$2
Fair value of options granted	$1,241,904	$81,884
Minimum [Member]
Assumptions for Pricing Model:
Expected term in years	5 years 7 months 6 days
Volatility	118.60%
Risk-free interest rate	1.70%
Maximum [Member]
Assumptions for Pricing Model:
Expected term in years	10 years
Volatility	119.70%
Risk-free interest rate	2.42%

Stock_Option_Plans_Additional_

Stock Option Plans (Additional Information) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2014
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Weighted average remaining contractual term on unvested options	6 years 9 months 18 days
Exercisable Options Outstanding Shares	257,786
Weighted average exercise price per share	$7.72
Unvested Options Outstanding, Shares	462,384
Unvested Options Outstanding, Weighted average exercise price	$2.63
Unvested Options Outstanding Weighted average remaining life (yrs)	9 years 7 months 6 days
Unrecognized stock compensation expense	$1,100,000
Weighted average recognition period	2 years 1 month 6 days
Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Shares Authorized	1,178,051
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage	100.00%
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	10 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value	$268,000
Employee Stock Option Plan
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Percentage Of Stock Option Vesting Period	20.00%
Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Shares Authorized	1,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum	10.00%
Non Employee Director
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Percentage Of Stock Option Vesting Period	50.00%
stock option plans [Member]
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Unvested Options Outstanding, Shares	462,765

Commitments_Future_Minimum_Pay

Commitments (Future Minimum Payments Required Under Operating Lease) (Detail) (USD $)	Dec. 31, 2014
Future Minimum Payments Required Under Operating Lease [Line Items]
2015	$81,080
Total Minimum Lease Payments	$81,080

Commitments_Additional_Informa

Commitments (Additional Information) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Commitment Contingencies Disclosure [Line Items]
Lease Expiration Date	30-Sep-15
Sale Leaseback Transaction, Monthly Rental Payments	$4,200
Operating Leases, Rent Expense	$116,743	$104,766

Employee_Benefit_Plans_Additio

Employee Benefit Plans (Additional Information) (Detail)	12 Months Ended
	Dec. 31, 2014
Employee Benefit Plans [Line Items]
Percentage Of Employee Deferrals	100.00%

Concentrations_Additional_Info

Concentrations (Additional Information) (Detail)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Concentrations [Line Items]
Percentage On Accounts Receivable	6.00%	79.00%
Sales Revenue, Net [Member]
Concentrations [Line Items]
Concentration Risk, Percentage	10.00%	17.00%

Related_Party_Transactions_Add

Related Party Transactions (Additional Information) (Detail) (USD $)	12 Months Ended	0 Months Ended
	Dec. 31, 2013	Aug. 05, 2013	Aug. 05, 2014	Dec. 31, 2014
Related Party Transactions Additional Information [Line Items]
Common Stock Price Per Share		$2	$2
Class of Warrant or Right, Exercise Price of Warrants or Rights		$2.25
Officer [Member]
Related Party Transactions Additional Information [Line Items]
Interest Expense, Debt	$32,507
Accrued Employee Benefits	107,209			0
Accrued Compensation
Related Party Transactions Additional Information [Line Items]
Decrease In Employee Related Liabilities Noncurrent		1,126,763
Accrued Interest
Related Party Transactions Additional Information [Line Items]
Decrease In Employee Related Liabilities Noncurrent		$515,806

Subsequent_EventsAdditional_In

Subsequent Events(Additional Information) (Detail) (USD $)	12 Months Ended			1 Months Ended		3 Months Ended
	Dec. 31, 2014	Dec. 31, 2013		Jul. 30, 2013	Jan. 02, 2015	Mar. 31, 2015	Aug. 05, 2013	Dec. 31, 2012
Subsequent Event [Line Items]
Stock Issued During Period, Value, New Issues		$8,050,000
Stockholders' Equity Attributable To Parent	-14,398,011	-13,038,293						-6,209,565
Derivative Liability, Noncurrent	13,541,138	12,035,816
Preferred Stock Shares Outstanding	0	0
Preferred Stock Shares Outstanding In Percent liquidation or amendment actions	60.00%
Cash, Period Increase (Decrease)	24,750,000
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period	10,819	0
Class of Warrant or Right, Exercise Price of Warrants or Rights							$2.25
Proceeds from Warrant Exercises	2,682,669	56,250
Class Of Warrant Or Right Outstanding	5,236,660	7,147,775						656,641
Debt Conversion, Converted Instrument, Amount	625,000	2,882,333
Payments of Stock Issuance Costs	0	1,204,779
Convertible Notes Payable	2,806,942
Common Stock [Member]
Subsequent Event [Line Items]
Stock Issued During Period, Shares, New Issues		4,025,000	[1]
Stock Issued During Period, Value, New Issues		4,025
Stockholders' Equity Attributable To Parent	11,296	9,600						3,537
Series A Preferred Stock [Member]
Subsequent Event [Line Items]
Preferred Stock, Dividend Rate, Percentage	6.00%
Preferred Stock Shares Outstanding In Percent	25.00%
Preferred Stock Shares Outstanding	12,406
Series A Preferred Stock [Member] | Director One [Member]
Subsequent Event [Line Items]
Preferred Stock Shares Outstanding In Percent	40.00%
Series A Preferred Stock [Member] | Director Two [Member]
Subsequent Event [Line Items]
Preferred Stock Shares Outstanding In Percent	20.00%
Series A Private Placement [Member]
Subsequent Event [Line Items]
Warrants Outstanding Percentage				86.00%
Subsequent Event [Member]
Subsequent Event [Line Items]
Preferred Stock, Liquidation Preference Per Share	$1,000
Stockholders' Equity Attributable To Parent	-14,398,011				22,400,000
Derivative Liability, Noncurrent					1,390,880
Class Of Warrant Or Right Outstanding						537,102
Debt Conversion, Converted Instrument, Amount						337,500
Payments of Stock Issuance Costs					150,000
Convertible Notes Payable						2,037,500
Subsequent Event [Member] | Common Stock [Member]
Subsequent Event [Line Items]
Convertible Preferred Stock, Shares Issued upon Conversion					100
Debt Conversion, Converted Instrument, Shares Issued						150,000
Debt Instrument, Convertible, Number of Equity Instruments						905,556
Subsequent Event [Member] | Common Stock [Member] | Stock Plan 2014 [Member]
Subsequent Event [Line Items]
Stock Issued During Period, Shares, Restricted Stock Award, Gross						295,000
Subsequent Event [Member] | Common Stock [Member] | Investor Relations Services [Member]
Subsequent Event [Line Items]
Stock Issued During Period, Shares, Restricted Stock Award, Gross						40,000
Subsequent Event [Member] | Series A [Member]
Subsequent Event [Line Items]
Shares Issued, Price Per Share					$5
Conversion of Stock, Amount Converted					500
Subsequent Event [Member] | August 2013 stock offering [Member]
Subsequent Event [Line Items]
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period						4,665,892
Class of Warrant or Right, Exercise Price of Warrants or Rights						$2.25
Proceeds from Warrant Exercises						1,135,125
Class Of Warrant Or Right Outstanding						65,100
Subsequent Event [Member] | August 2013 stock offering [Member] | Cash [Member]
Subsequent Event [Line Items]
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period						504,500
Subsequent Event [Member] | August 2013 stock offering [Member] | Common Stock [Member]
Subsequent Event [Line Items]
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period						3,551,281
Subsequent Event [Member] | Intel Corporation [Member] | Series A Preferred Stock [Member]
Subsequent Event [Line Items]
Stock Issued During Period, Shares, New Issues					49,626
Shares Issued, Price Per Share					$500
Stock Issued During Period, Value, New Issues					$24,813,000
Conversion of Stock, Description					Each share of Series A Preferred Stock is convertible, at the option of the Series A Purchaser, into 100 shares of the Company’s common stock (determined by dividing the Series A Original Issue Price of $500 by the Series A Conversion Price. The Series A Conversion Price is $5.00, subject to adjustment in the event of stock splits, dividends or other combinations).
Subsequent Event [Member] | Cashless [Member] | August 2013 stock offering [Member]
Subsequent Event [Line Items]
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period						4,161,392
[1]	All share amounts for all periods reflect the Companybs 1-for-75 reverse stock split, which was effective February 6, 2013.